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Abstract
! With an increase in early detection and curative treatment for breast cancer, 
there is a growing number of breast cancer survivors. Cancer survivors are at greater 
risk than their age matched peers for long-term health sequelae including recurrence of 
primary tumors and cardiovascular disease (CVD). Besides the direct effects of cancer 
treatment and a genetic predisposition, lifestyle factors are believed to contribute to 
these comorbid conditions. Despite knowing the benefits associated with an active 
lifestyle, breast cancer survivors have reported to decrease their activity level by as 
much as two hours or more per week, based on their treatment regimen. Guidelines for 
diet and/or exercise targeting cancer survivors have been proposed, but a paucity of 
data is available on optimal interventions for improving lifestyle behavior change in this 
population.
! This dissertation was undertaken to address important unanswered questions.  
Specifically, can prescribed home-based exercise dosing be performed in a safe and 
effective manner during a combined diet and exercise intervention?  And, will 
cardiovascular exercise dosing help improve selected outcomes of interest for breast 
cancer survivors?
! Initially, we performed a cross-sectional study to investigate the cardiorespiratory 
fitness (VO2max) level and body composition (weight, BMI, % body fat) in breast cancer 
survivors. We reported that breast cancer survivors had a low VO2max compared to 
normal values in a healthy population. In addition, submaximal VO2 exercise testing on 
a treadmill and elliptical trainer had a strong correlation to the gold standard test for 
measuring cardiorespiratory fitness on a treadmill.  
iii
! Next, we undertook study to investigate the feasibility of using cardiovascular 
exercise dosing during a 17 week combined diet, home-based exercise, and behavior 
modification intervention. For simplicity, we will refer to this 17 week intervention as the 
“Energy Balance Program” throughout the remainder of this dissertation. In addition to 
investigating feasibility, we analyzed the potential for cardiovascular exercise dosing to 
have different effects on CVD and breast cancer risk factors including low VO2max and 
weight gain during an Energy Balance Program. Nineteen female breast cancer 
survivors participated in an Energy Balance Program. One cohort received “usual care”  
cardiovascular exercise instructions including moderate continuous exercise (MCT) and 
a second cohort was prescribed cardiovascular exercise dosing in the form of interval 
training (IT). Both groups reported significant improvements in VO2max and body 
composition. Additionally, the IT group had a significantly greater improvement in VO2max 
compared to MCT, without any cardiovascular related adverse events (AE).
! In conclusion, we were able to demonstrate a high correlation between sub-
maximal and maximal exercise testing using both the treadmill and arc trainer in breast 
cancer survivors at high risk for CVD. In addition, breast cancer survivors in our study 
had a low VO2max, but were able to successfully participate in a home based exercise 
and weight loss program, resulting in significant improvements in body composition and 
VO2max, with significantly greater improvements in the IT versus MCT group for VO2max. 
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! Approximately 227,000 women were estimated to be diagnosed with and over 
39,510 deaths will be attributed to breast cancer in 2012 (ACS, 2012). Early detection 
and targeted therapy have resulted in a new chronic disease population in many 
developed countries (K. H. Schmitz, Stout, Andrews, Binkley, & Smith, 2012).  
Consequently, a trend towards a growing population of women surviving after diagnosis 
exceeds 2.5 million breast cancer survivors in the United States (ACS, 2012). Incidence 
rates for breast cancer in the United States remained constant between 1999 and 2008, 
but the death rates decreased for the same period (Eheman, et al., 2012). This 
decrease in breast cancer mortality was only seen in women older than 50, and may be 
influenced by a decline in the use of hormone therapy after menopause (ACS, 2012). 
Therefore, an increasing population of breast cancer survivors are faced with unique 
challenges including physiological and psychological sequelae as a result of the direct 
and indirect effects of their cancer treatment (Hewitt, Rowland, & Yancik, 2003). 
! The long-term effects of cancer treatment may lead to accelerated declines in 
physical function compared to those living without a history of cancer (K. H. Schmitz, 
Cappola, Stricker, Sweeney, & Norman, 2007). Greater than 75% of breast cancer 
survivors will live ten years after diagnosis, but suffer from late and long-term effects of 
breast cancer treatment on total body systems (NCI, SEER 1996-2007). Multiple 
physiological systems including cardiorespiratory and muscular endurance contribute to 
optimal physical function (Hewitt, et al., 2003; K. H. Schmitz, et al., 2007); and there is 
evidence that adjuvant therapy during breast cancer treatment can alter 
cardiorespiratory function. Studies have shown radiation therapy (Lind, et al., 1998; Ooi, 
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et al., 2001) and chemotherapy agents (Ng, Better, & Green, 2006; Theuws, et al., 
1999) can be toxic to the heart and lungs, especially when used in combination 
(Shapiro, et al., 1998; Shapiro & Recht, 2001). Thus, the effects of breast cancer 
treatment can contribute to a diminished functional mobility mediated through the effects 
to the cardiorespiratory system. 
! Observational evidence from the Nurses’ Health Study has described that breast 
cancer survivors experience long-term functional mobility (moderate and vigorous 
intensity activities) deficits, measured by self-reported survey (SF-36), when compared 
to women with no history of cancer (Michael, Kawachi, Berkman, Holmes, & Colditz, 
2000). The decline in activity can be instrumental in both pre- and post-menopausal 
weight gain, which is common after a breast cancer diagnosis (Goodwin, et al., 2002; 
Vance, Mourtzakis, McCargar, & Hanning, 2011). The Annual Report to the Nation on 
the Status of cancer suggests that weight gain and insufficient activity contributes to the 
increased incidence of many cancers and adversely affects the quality of life in cancer 
survivors (Eheman, et al., 2012). 
! Recurrence of the primary malignancy and cardiac events are the leading causes 
of death in long-term cancer survivors, while the incidence of cardiac events and 
occurrence of breast cancer share common modifiable risk factors (Figure 1.1). 
Strategies for improving long-term health outcomes for the growing number of breast 
cancer survivors are important due to the increased prevalence of CVD and risk for 
recurrence of cancer. This dissertation begins by introducing an intervention model for 
targeting factors related to tumorigenesis and CVD in breast cancer survivors that 
display risk factors for both diseases. Figure 1.2 depicts the breast cancer survivor 
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disease prevention model. Two primary components of the model are: 1) identify those 
at risk due to targeted modifiable risk factors, and 2) determine an effective intervention 
strategy for decreasing CVD and recurrence risk. Studies suggest that combined diet 
and exercise interventions improve weight and physical activity as seen in Table 1.1 
(Pekmezi & Demark-Wahnefried, 2011). A recent group home-based treatment delivery 
approach using combined diet and exercise reported significant improvements in weight 
loss and physical activity in breast cancer survivors (Befort, et al., 2012). Additionally, 
diet and physical activity guidelines targeting cancer survivors have been issued by the 
American Cancer Society (ACS) and American College of Sports Medicine (ACSM)
(Doyle, et al., 2006; K. H. Schmitz, et al., 2010). However, more research is needed on 
different exercise prescriptions and their effect on targeted sustainable outcomes in 
breast cancer survivors.          
!   
Women Diagnosed with Breast Cancer: A Population Already at Risk for CVD
! The Framingham study estimated that women over 50 years of age, with 2 or more 
CVD risk factors, had a 50% lifetime risk of developing CVD (Lloyd-Jones, et al., 2006). 
Physical inactivity and weight gain are two independent risk factors associated with 
CVD, but have been overlooked when assessing cardiovascular outcomes after 
adjuvant treatment (Jones, Haykowsky, Swartz, Douglas, & Mackey, 2007). It is 
reported that 62% of breast cancer survivors are overweight (Irwin, et al., 2005) and 
36% are sedentary (Jones, Courneya, Fairey, & Mackey, 2004), while the average age 
of a breast cancer survivor is 61 (Hayat, Howlader, Reichman, & Edwards, 2007). 
Based on these estimates, a good percentage of women diagnosed with breast cancer 
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may already have a significant risk of CVD. Moreover, this risk at diagnosis may be 
amplified by the combined direct and indirect effects of breast cancer treatment. The 
direct treatment effects (adjuvant therapy, radiation, hormone therapy) may increase the 
risk of cardiac dysfunction (ASCO, 2007), but other indirect effects such as weight gain, 
physical inactivity, and other lifestyle factors may play a role as well. Therefore, it could 
be speculated that breast cancer survivors may have an elevated risk for CVD, 
independent of the direct effects of adjuvant treatment, due to their unfavorable risk 
profile.
1.2 Adjuvant Therapy (Direct Effects)  
! Cancer treatment may impact the long-term health of survivors (ASCO, 2007), in 
part due to functional declines in major organ systems including the heart, lungs, 
muscle, and bones. Cardiovascular disease has been identified as a leading cause of 
mortality in older female breast cancer survivors. A study by Patnaik et al. followed 
63,566 women (66 years of age and older) diagnosed with breast cancer for a median 
of nine years and revealed that mortality due to CVD was greater than breast cancer 
(Patnaik, Byers, DiGuiseppi, Dabelea, & Denberg, 2011). In addition, CVD remains the 
major cause of nonmalignant death in long-term survivors of Hodgkin lymphoma who 
are exposed to cardiotoxic treatment similar to breast cancer therapy (Aleman, et al., 
2007).  
! Chemotherapy agents necessary for treating disease may have lasting effects on 
the cardiac function of breast cancer survivors. Studies investigating the effects of 
anthracycline based chemotherapy revealed a 20% to 51% reduction in cardiac function 
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(Bear, et al., 2006; Bonneterre, et al., 2004; Martin, et al., 2005; Perez, et al., 2004). 
Anthracyclines are a common chemotherapy agent for treating breast cancer, despite 
their well-known risk for inducing cardiac dysfunction. It is estimated that at least 20% of 
cancer patients who receive anthracyclines, including the best-known Adriamycin/
Doxorubicin (Dox), experience damage to left ventricular function, which weakens the 
heart muscle and depletes the organ's pumping strength (Clements, Davis, & Wiseman, 
2002). Furthermore, symptoms related to cardiac dysfunction may not manifest for 
years after treatment (Shan, Lincoff, & Young, 1996). The direct effects of treatment 
may contribute to a functional decline in the breast cancer survivor's physical capacity, 
including cardiorespiratory fitness. A reduced physical capacity may lead to increased 
inactivity and weight gain for the breast cancer survivor.      !  
! Adjuvant therapy may also include the long-term use of hormone therapy, 
including Aromatase Inhibitors (AI). Estrogen plays a central role in the development 
and progression of breast cancer and AI’s are used to prevent the synthesis of estrogen 
during adjuvant treatment of breast cancer patients and are replacing tamoxifen as the 
mainstay hormone therapy in post-menopausal breast cancer survivors. AI’s have 
demonstrated to be more effective than tamoxifen due to an improvement in disease 
free survival and reductions in early distant metastasis, resulting in better overall 
survival (Janni & Hepp, 2010). In addition, AI’s has been recognized to have a “better” 
risk profile than tamoxifen since they are associated with less life threatening 
thromboembolic events and endometrial cancer (Howell, et al., 2005). However, 
estrogen deprivation with AI’s may negatively impact lipids, leading to more 
cardiovascular problems compared to tamoxifen (Smith, 2004). 
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! A meta-analysis including seven randomized controlled trials (n= 19,818) revealed 
a significant increase in the number of cardiovascular events with the use of AI’s versus 
tamoxifen (RR, 1.31; p = 0.007) (Cuppone, et al., 2008). AI’s can suppress estradiol 
levels in postmenopausal women by as much as 84%, but they may cause an increase 
in inflammatory cytokines (Nabholtz, 2008). There is little data available to assess long-
term cardiac health while using AI’s (Janni & Hepp, 2010) and the cardiac safety of AI’s 
compared to tamoxifen is still unclear. More studies are needed to determine the 
therapeutic benefit of AI’s during adjuvant treatment. A better understanding of the 
potential for long-term side effects of AI’s and their risk-to-benefit ratio is needed 
because it may impact QoL in breast cancer survivors (Janni & Hepp, 2010). 
! Cardiorespiratory fitness may suffer as a result of hormone therapy in long-term 
breast cancer survivors. Suppressing the hormone estrogen may have deleterious 
physiological effects on the delivery of oxygen to working tissues (Jones, Eves, 
Haykowsky, Freedland, & Mackey, 2009), possibly modifying the cardiorespiratory 
fitness of breast cancer survivors. In a study by Jones and colleagues they find that 
breast cancer survivors treated with AI’s had a more unfavorable metabolic profile 
compared to those treated with tamoxifen. Specifically, breast cancer survivors treated 
with AI’s had a significantly higher BMI (30 +/- 6 vs. 26 +/- 4 kg/m2), fasting insulin (11.3 
+/- 5.9 vs. 7.3 +/- 4.3 mmol/L), and fasting glucose (5.9 +/- 1.2 vs. 5.3 +/- 0.5 mmol/L)
(Jones, Haykowsky, Pituskin, et al., 2007). A poor metabolic profile may adversely affect 
cardiac function and diminish the oxidative capacity of working muscle tissue, negatively  
impacting cardiorespiratory fitness. 
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! Most research in oncology is limited to symptomatic patients during the acute 
phase of treatment. There is little data demonstrating potential late and long-term 
cardiac side effects from newer, more targeted therapies that are becoming common 
practice. Breast cancer patients receiving combination therapy may be most susceptible 
to compounded cardiac damage but there is limited evidence of any preventive 
measures that can alter the natural history of cardiac disease in asymptomatic cancer 
survivors (ASCO, 2007). Thus, combined treatment including chemotherapy and 
hormonal therapy may increase likelihood of cardiac disease well into survivorship.
1.3 Modifiable Lifestyle Risk Factors (Indirect Effects)
! The double impact of treatment (Direct effects) and lifestyle (Indirect effects) can 
cause a decline in long-term health for breast cancer survivors. Inactivity and increased 
weight are common lifestyle risk factors experienced by breast cancer patients from the 
day of diagnosis, throughout treatment, and transitioning into survivorship. It has been 
previously reported that breast cancer survivors decreased their physical activity by 2 
hours per week after diagnosis compared to pre-diagnosis, with a larger decline in 
physical activity for those receiving adjuvant treatment versus single modality therapy 
(Irwin, et al., 2003). Investigators have shown that decreased activity may be associated 
with increased recurrence (Holmes, Chen, Feskanich, Kroenke, & Colditz, 2005; 
Winzer, Whiteman, Reeves, & Paratz, 2011) and decreased survival. Body Mass Index 
(BMI) has also been shown to adversely affect survival rates (McTiernan, Irwin, & 
Vongruenigen, 2010; Protani, Coory, & Martin, 2010). In addition, modifiable risk factors 
including weight and inactivity have been linked to an increased risk for developing 
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primary breast cancer. Specifically, obesity was associated with a 63% increased breast 
cancer risk (Calle, Rodriguez, Walker-Thurmond, & Thun, 2003) and inactivity attributed 
to a 2-15% elevated risk of breast cancer (Clarke, Purdie, & Glaser, 2006). The double 
impact of the direct and indirect effects of breast cancer treatment may have a 
synergistic relationship that leads to an increased chance for breast cancer recurrence 
and decreased survival.!
! Current cancer treatments have become effective at treating the malignancy, but 
may have unintended side effects on long-term health. Late and long-term effects of 
cancer treatment include pain, cancer related fatigue, and diminished cardiorespiratory 
fitness(Courneya & Friedenreich, 2001). Additionally, breast cancer treatment is 
associated with physiological effects on body systems including pulmonary, cardiac, and 
musculoskeletal function, thus contributing to decreased activity (K. Schmitz, 2011). 
Declining physical activity related to the effects of cancer treatment may contribute to 
the diminished cardiorespiratory fitness and increased weight observed in these 
individuals. 
! Physical risk factors including decreased cardiorespiratory fitness and increased 
fat mass may contribute to dysregulated metabolic factors that negatively impact long-
term health of breast cancer survivors. Excess weight and physical inactivity can raise 
circulating levels of insulin (Eheman, et al., 2012). Chronic high insulin levels may play 
an independent role in tumorigenesis (Donohoe, Doyle, & Reynolds, 2011; Gallagher & 
LeRoith, 2011) and may increase risk of breast cancer and all-cause mortality 
(Goodwin, et al., 2002). In addition, cardiovascular mortality is increased among insulin 
resistant patients (Huisamen, et al., 2012). 
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Breast Cancer and Weight Gain!
! Weight gain in breast cancer survivors has been shown to significantly increase 
cardiovascular disease mortality (Nichols, et al., 2009). For example, each 5-kg gain in 
weight after breast cancer diagnosis was associated with a 12%, 13%, and 19% 
increase in all-cause, breast cancer, and CVD mortality, respectively (Nichols, et al., 
2009). In addition, breast cancer survivors with a BMI greater than 25 kg/m2 have up to 
a 60% increased risk for death compared to survivors with normal body weight (Saxton, 
et al., 2006). Breast cancer survivors undergoing adjuvant chemotherapy experience an 
increase in fat mass (a component of BMI), with no change or decrease in lean mass, 
known as sarcopenic obesity (Demark-Wahnefried, et al., 2001). This change in body 
composition may create a physical environment rich in metabolic factors that adversely 
affect the health of breast cancer survivors. 
! Overweight/obesity may influence the mechanisms that can play a role in breast 
cancer and CVD risk. Overweight/obesity is associated with higher concentrations of 
endogenous estradiol, insulin, and inflammatory markers (Renehan, Roberts, & Dive, 
2008). In turn, risk factors including elevated BMI (Renehan, Tyson, Egger, Heller, & 
Zwahlen, 2008), central adiposity (Harvey, et al., 2005), elevated glucose (Muti, et al., 
2002), and insulin (Goodwin, 2008; Patterson, Cadmus, Emond, & Pierce, 2010), have 
an association with breast cancer and CVD risk. Obesity is dependent on the percent 
body fat (adipose tissue), and adipose tissue is the main source of estrogen 
biosynthesis in postmenopausal women (Baer, et al., 2005). In addition, estradiol is a 
potent physiological form of estrogen, and is synthesized in adipose tissue. The risk for 
developing breast cancer can increase five-fold when estradiol levels increase from 5 
10
pg/ml to 11 pg/ml. Therefore, lifestyle related risk factors may contribute to an increase 
in metabolic risk factors associated with breast cancer and CVD risk.
!   
Breast Cancer and Low Cardiorespiratory Fitness
! Inactivity may lead to a low cardiorespiratory fitness level (measured as VO2max) 
contributing to all-cause (Blair, et al., 1989) and cardiovascular (Blair, et al., 1996) 
mortality. Specific to CVD, decreased physical activity levels have a strong association 
with CVD in breast cancer patients, indicating that interventions to improve 
cardiorespiratory fitness may be important (Jones, Haykowsky, Pituskin, et al., 2007). In 
addition, women with a low fitness level can be at greater risk for breast cancer 
mortality. Alarmingly, women without a history of cancer who underwent a maximal 
exercise test and performed at 8 METS (28 ml/kg/min VO2) or below had nearly a three-
fold increased chance of breast cancer mortality compared to those who reached a level 
above 28 ml/kg/min VO2 (Peel, et al., 2009). Using a standardized measure of 
cardiorespiratory fitness will be helpful to quantify the effectiveness of an exercise 
program for breast cancer survivors (McNeely, et al., 2006). Cardiorespiratory fitness 
can be objectively measured with VO2max, and VO2max has been associated with CVD 
occurrence and breast cancer mortality (Speck, Courneya, Masse, Duval, & Schmitz, 
2010). Efforts should be made to improve cardiorespiratory fitness in breast cancer 
survivors in order to increase the likelihood for healthy outcomes.
! There is a paucity of data that describes cardiorespiratory fitness in long-term 
breast cancer survivors. More studies are needed to identify any association between 
cardiorespiratory fitness with breast cancer and CVD risk in breast cancer survivors who 
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are 5 years, 10 years, and longer post-treatment. Also, it would be beneficial to measure 
cardiorespiratory fitness at time of diagnosis to explore any decline over the continuum 
of care in breast cancer survivors. Our findings within this dissertation highlight the need 
for healthy lifestyle change in breast cancer survivors due to low cardiorespiratory 
fitness.
1.4 Exercise and Breast Cancer Survivors
! Regular physical exercise may reduce the risk of death from recurrence of breast 
cancer in survivors (Holmes, et al., 2005). It is important to note that low levels of 
physical activity may be the most modifiable of all the plausible risk factors for breast 
cancer (Neilson, Friedenreich, Brockton, & Millikan, 2009). In addition, exercise has 
been shown to have a positive effect on breast cancer risk factors including decreased 
estrogen (Lynch, Neilson, & Friedenreich, 2011; Neilson, et al., 2009; Winzer, et al., 
2011) and decreased insulin (Friedenreich, et al., 2011; Winzer, et al., 2011).
! Physical activity is being investigated to determine its effectiveness for improving 
long-term health in breast cancer survivors. The indirect effects of cancer treatment can 
have a negative impact on breast cancer survivors’ health and quality of life. A recent 
review focusing on physical activity, diet, and adiposity pointed out that in breast cancer 
survivors, increased adiposity appeared to be associated with a 30% increase in 
mortality and an increase in physical activity with a 30% decrease in mortality 
(Patterson, et al., 2010). Even though modifiable lifestyle factors are achievable, a 
majority of breast cancer survivors are overweight or obese (Pinto, et al., 2002). Only 
39% indicated they consumed a low-fat diet and exercised at recommended levels 
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(Pinto, et al., 2002). Breast cancer survivors who modify their lifestyle with diet and 
exercise may have a better long-term QoL compared to those who continue to gain 
weight and remain inactive. A study performed by Pierce and colleagues showed that 
breast cancer survivors who engaged in both healthy diet and exercise behaviors had a 
50% reduced risk of all-cause mortality (Pierce, et al., 2007).
! Research indicates exercise provides health benefits positively affecting breast 
cancer and CVD risk factors for breast cancer survivors. Lifestyle interventions including 
diet and exercise improved weight, fat mass, lean mass, and lipids for breast cancer 
survivors (Irwin, et al., 2009; Mefferd, Nichols, Pakiz, & Rock, 2007; K. H. Schmitz, 
Ahmed, Hannan, & Yee, 2005; Thomson, et al., 2010). In a study recently completed by 
our team of investigators (Klemp JR, 2009), we found that post-menopausal overweight 
breast cancer survivors who participated in a 6-month structured diet, exercise, and 
behavioral intervention lost an average of 11% of their initial body weight, >5% fat mass, 
and had a four-fold increase in their minutes of cardiovascular exercise (Klemp JR, 
2009). Systematic reviews and meta-analysis revealed that a majority of the studies 
including exercise interventions had a positive and significant impact on aerobic fitness 
during and post cancer treatment (Galvao & Newton, 2005; McNeely, et al., 2006; 
Speck, et al., 2010).
! To our knowledge, there have been no studies investigating the improvement in 
VO2max and additional breast cancer or CVD risk factors in breast cancer survivors when 
comparing between weight loss alone, exercise alone, or weight loss plus exercise. 
However in a recent 12-week randomized intervention, obese participants were 
randomized to exercise only, calorie restriction only, or exercise and calorie restriction.  
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The results indicated a significant increase in VO2max from the exercise alone or the 
combined exercise and calorie restriction intervention (14% and 18%, respectively), but 
found no change in VO2max in the calorie restriction alone group (Christiansen, Paulsen, 
Bruun, Pedersen, & Richelsen, 2010). In a similar 6-month intervention in overweight 
(non-cancer) participants, caloric restriction only versus caloric restriction plus aerobic 
exercise versus weight maintenance diet, VO2max significantly improved (increased) in the 
caloric restriction plus aerobic exercise arm only, 22+/-5% vs 7+/-5% (caloric restriction 
alone), vs -5+/-3% (weight maintenance diet) (Larson-Meyer, Redman, Heilbronn, 
Martin, & Ravussin, 2010). Based on these previous studies, interventions targeting 
cardiorespiratory fitness may not significantly improve VO2max without the exercise 
component. 
! The evidence is growing relating to the positive effects of exercise in breast cancer 
survivors as depicted in the previously mentioned studies. In addition, a recent meta-
analysis revealed sixty-six high quality studies investigating the positive impact physical 
activity has on several outcomes including body weight and cardiorespiratory fitness in a 
heterogeneous group of cancer patients and survivors (Speck, et al., 2010). A more 
recent review focusing only on cancer survivorship, rather than during and post 
treatment, revealed that diet only interventions improved diet quality, nutrition-related 
biomarkers, and body weight while exercise only interventions improved fitness, 
strength, physical function, and psycho-social variables (Pekmezi & Demark-
Wahnefried, 2011). The American Cancer Society advocates combining diet and 
exercise interventions, but few studies involving combined interventions are available. 
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Specifically, there have been five randomized controlled trials performed in the last 
three years incorporating combined diet and exercise interventions (Table 1.1).
! Although, the two recent reviews supported exercise interventions for cancer 
patients and during survivorship, the authors concluded important questions remain to be 
unanswered. First, more work is needed to help us understand the dose of exercise to 
generate the greatest improvement in targeted outcomes. Expanding our knowledge on 
the dose response of exercise training can assist us in developing specific exercise 
guidelines for cancer survivors. Next, the reviewers noted that they did not account for the 
possible differences between supervised versus home-based exercise interventions   
(Speck, et al., 2010).  
! Two studies in the review conducted by Pekmezi et al. involved breast cancer 
survivors, but none included cardiovascular exercise dosing to determine improvements 
in cardiorespiratory fitness in the design. In addition, none of the studies included 
VO2max for measuring improvement in cardiorespiratory fitness. Jones and colleagues 
are studying the effects of cardiovascular exercise dose intensity on VO2max in breast 
cancer survivors during a supervised intervention (Jones, et al., 2010). In contrast to 
Jones’ study, this dissertation will use a home-based intervention to investigate the 
effects cardiovascular exercise dose intensity has on VO2max. Therefore, the 
environment where the exercise training may have the best chance of achieving 
sustainability should be considered.  
!
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1.5 Home-Based Exercise Program
! Four of the five studies reviewed by Pekmezi et al. indicate a trend in home-based 
and semi-supervised interventions. Lifestyle change including diet and exercise may be 
more sustainable when the interventions are home-based and semi-supervised 
(Pekmezi & Demark-Wahnefried, 2011). From a practical point of view, it’s difficult for 
many adults to balance work, kids, domestic life, and a scheduled supervised exercise 
program into their weekly regimen. Many breast cancer survivors may find it difficult to 
sustain any fitness gains made from a supervised exercise program since they may not 
be able to maintain routine visits to monitored sessions. Therefore, we should caution 
recommending exercise dose prescription based on small samples of people from 
supervised studies, when comparing such studies to the general home-based activity 
preference of breast cancer survivors (Blair, LaMonte, & Nichaman, 2004). 
! It seems appropriate to design exercise interventions that support the needs of the 
target population if we eventually want to reach a large number of breast cancer 
survivors. When designing interventions for breast cancer survivors we should consider 
environmental factors that may influence exercise preferences (Rogers, Courneya, 
Verhulst, Markwell, & McAuley, 2008). A home-based intervention to promote exercise 
has been preferred over visiting a fitness facility or cancer center by a majority of the 
breast cancer survivors (Jones & Courneya, 2002; Rogers, Courneya, Shah, 
Dunnington, & Hopkins-Price, 2007; Rogers, Markwell, Verhulst, McAuley, & Courneya, 
2009). Therefore, it’s possible interventions focusing on the promotion of exercise in the 
home environment will help increase adherence to behavior change in a larger number 
of breast cancer survivors. 
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! Ultimately, we would like to see a favorable exercise adherence rate in home-
based studies to assure efficacy of the prescribed intervention. Prior studies have 
investigated adherence to home-based exercise interventions with mixed results. A 
previous study by Duncan et al. showed that adherence to prescribed exercise ranged 
from an undesirable 57.8% - 68.8% during a home based intervention for sedentary 
adults (Duncan, et al., 2005). However, another study by King et al. showed that a 
home-based exercise program produced a significantly higher (P < 0.001) adherence 
rate versus a supervised community based program in healthy sedentary adults (King, 
Haskell, Taylor, Kraemer, & DeBusk, 1991). In addition, home-based interventions have 
produced similar improvements in VO2peak and exercise participation in obese women 
and sedentary adults compared to a supervised group exercise program (King, et al., 
1991; Perri, Martin, Leermakers, Sears, & Notelovitz, 1997).
! This study will provide the next steps in developing future home-based exercise 
prescriptions for breast cancer survivors to improve targeted outcomes including CVD 
and breast cancer risk factors. Targeting breast cancer and CVD risk factors seems 
plausible since recurrence is the leading cause of mortality, and CVD incidence 
increases in survivors (ASCO, 2007). Furthermore, it is still unclear what dose of 
exercise would be the safest and most effective dose to achieve the most meaningful 
improvement in targeted outcomes (Galvao & Newton, 2005). There is a lack of 
evidence investigating the most effective exercise dose-response to improve quality of 
health in breast cancer survivors (McNeely, et al., 2006) and we need to tailor exercise 
interventions to focus on type (K. Schmitz, 2011) and dose (Lynch, et al., 2011) of 
exercise that may relate to reducing breast cancer and CVD risk. This study aims to 
17
address these limitations by exploring feasibility of two different cardiovascular exercise 
doses during a home-based exercise program (Aim 1), and determining the impact 
cardiovascular exercise dosing has on improving VO2max and weight loss (Aim 2). We’ll 
use an exercise methodology to investigate the role of cardiovascular dose-intensity 
exercise for breast cancer survivors.
! Assessing cardiorespiratory fitness by measuring VO2 provides an accurate tool 
for identifying the success of an exercise program. An objective measure of fitness is 
essential to accurately assess improvement after an exercise intervention, as well as, 
respond to the need for a standardized measure of fitness in breast cancer survivors 
(McNeely, et al., 2006). To our knowledge, no studies in breast cancer survivors include 
the gold standard cardiorespiratory fitness measure (VO2max) to assess baseline and 
changes after an Energy Balance Program. We plan to measure VO2max during a 
cardiorespiratory test, while assessing the feasibility of two separate cardiovascular 
exercise dose intensities during an Energy Balance Program. Cardiorespiratory testing 
can provide an objective evaluation of fitness, reducing the variability found in self-
reported activity measures by 70-80% (Blair & Church, 2004). Therefore, we’ll be able 
to quantify cardiorespiratory fitness change after using two separate cardiovascular 
exercise dose intensities during an Energy Balance Program for breast cancer 
survivors.
1.6 Cardiovascular Exercise Dose Response      
! Two exercise intensity doses include Moderate Continuous Training (MCT) and 
Interval Training (IT). Clinical practice may benefit from a better understanding of a 
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specific training dose to produce the best health outcomes in breast cancer patients. An 
earlier review indicated that more prospective studies are needed to investigate 
exercise dosing in cancer populations as a whole (Galvao & Newton, 2005). MCT 
focuses on an aerobic exercise intensity at or near 50-70% of maximal achieved Heart 
Rate (HR). MCT is aerobic in nature and has effectively reduced all-cause and cardiac 
mortality rates (Jolliffe, et al., 2000). Evidence suggests the training characteristic of 
MCT improves aerobic capacity mostly due to oxygen extraction at the muscle 
(Daussin, et al., 2008).
      ! In contrast, IT produces a training dose that includes aerobic and anaerobic 
metabolic demands, involving perturbations of exercise intensity within an approximate 
60-95% of maximal achieved HR. IT benefits both anaerobic and aerobic systems 
allowing a better response to peak aerobic fitness than MCT due to cardiac and skeletal 
muscle metabolic demands (McArdle, 2007). Cardiac function may be improved with 
short bouts of anaerobic activity while meeting the essential need of more blood flow to 
working skeletal muscle. Cardiac performance can be enhanced with anaerobic 
exercise due to improvement in left ventricular filling and contractility (stroke volume) 
(Wigmore, 2011), with filling providing a good portion of enhanced cardiac function 
leading to an elevated cardiac output (CO) (Ferguson, Gledhill, Jamnik, Wiebe, & 
Payne, 2001; Gledhill, Cox, & Jamnik, 1994). Improvement of diastolic function as 
identified by augmented left ventricular filling is important since diastolic dysfunction has 
been theorized to be a major effect of chemotherapy induced cardiotoxicity (Shan, et al., 
1996). This dissertation explores if IT may be a cardiovascular exercise dose-response 
that improves VO2max to a greater extent than MCT. 
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IT: From Cardiac Function to Cardiorespiratory Fitness
! The double impact of breast cancer treatment may lead to diminished ventricular 
function, resulting in a diminished QoL for breast cancer survivors. The combined 
effects of toxicity and inactivity may weaken the heart muscle of breast cancer survivors. 
This cardiac dysfunction can be caused by dilated ventricles and a decrease in 
ventricular wall thickness inducing a diminished stroke volume (Wigmore, 2011), 
ultimately resulting in a reduction of CO and increased workload on the heart during 
activity. Breast cancer survivors had less available blood delivered to their working 
muscles compared to non-cancer peers due to a reduced CO (10.4 + 1.5 vs. 11.7 + 2.4 
L/min, P= 0.02) during maximal cardiorespiratory testing on a cycle ergometer (Jones, 
Haykowsky, Pituskin, et al., 2007). If ventricular function is compromised in cancer 
survivors, usually due to the effects of dilated cardiomyopathy (ASCO, 2007), 
dysfunction of ventricular contractility and relaxation will limit the working muscles of the 
required blood flow to meet the energy demands during exertion. This deficit in blood 
flow to working tissues may lead to early onset fatigue, shortness of breath, and 
ultimately a diminished exercise capacity.
! Interval training may improve stroke volume, and ultimately cardiorespiratory 
fitness, more than MCT in breast cancer survivors. Ability to increase CO depends on 
heart rate and stroke volume, with stroke volume contingent on ventricular filling and 
contractility. As exercise intensity progresses into an anaerobic state, stroke volume 
increases secondary to increased contractility of the left ventricle. Adaptations including 
contractility of the left ventricle will increase amount of oxygenated blood available to 
working muscles. Whole body oxygen consumption (VO2max) will increase in proportion 
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to exercise intensity and is a result of cardiac output (CO) and skeletal muscle oxygen 
uptake (Wigmore, 2011). Physiological adaptations to IT can include a more efficient 
stroke volume due to the increasing metabolic demands of working muscle as a result 
of a higher exercise intensity. The human body may adapt to the physiological stress 
induced by different exercise intensities. Ultimately, anaerobic exercise during IT 
induces physiological changes including cardiac function, leading to improved VO2max.
IT and Cardiorespiratory Fitness
! There is a limited amount of data on IT in female populations, but IT has shown 
to significantly improve VO2max in children (Baquet, et al., 2010), sedentary adults 
(Daussin, et al., 2008), pulmonary patients (Arnardottir, Boman, Larsson, Hedenstrom, 
& Emtner, 2007), CAD patients (Moholdt, et al., 2009; Rognmo, Hetland, Helgerud, Hoff, 
& Slordahl, 2004; Warburton, et al., 2005; Wisloff, et al., 2007), heart failure patients 
(Dimopoulos, et al., 2006; Nechwatal, Duck, & Gruber, 2002), and adults with metabolic 
syndrome (Tjonna, et al., 2008). Table 1.2 shows ten separate randomized trials in the 
past ten years that used IT in different populations. To the best of our knowledge, no 
studies have been completed on breast cancer patients that use IT. However, one such 
study is currently investigating the effects of IT on breast cancer and CVD risk factors in 
breast cancer survivors during a highly supervised intervention (Jones, et al., 2010). 
! Interval training may help enhance tolerance to exercise due to greater 
improvement of cardiac function and oxygen uptake (VO2max) compared to MCT. In a 
study with sedentary adults, IT was involved with greater changes within groups in CO 
and VO2max from baseline and significantly greater (P < 0.05) improvements between 
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groups in time to exhaustion, ultimately leading to greater changes within groups in 
VO2max (Daussin, et al., 2007; Daussin, et al., 2008). Eleven sedentary subjects (7 men 
and 4 women) were assigned to either a MCT or an IT program. The training consisted 
of 3 sessions per week for 8 weeks. After the initial training program, all subjects went 
through a detraining period of 12 weeks, then reassigned in a randomized cross-over 
design to the opposite training regimen from their initial program. The duration of the 
MCT and IT program was equal, building up to 35 minutes per session over the last 2 
weeks. The IT program included blocks of 5 minutes with 4 minutes at power output 
(watts) achieved at the ventilatory threshold (VT) and 1 minute at 90% of peak power 
output. VT and peak power output were determined from a maximal cardiorespiratory 
exercise with gas analysis performed on a bike ergometer. MCT was performed at the 
power output consistent with power achieved at VT, based on the following formula: [4 x 
PVT1 + 90% of Pmax/5] (Daussin, et al., 2008). The prescribed intensities of both 
programs allowed for similar energy expenditures. IT appeared to improve functional 
exercise capacity due in part to significant changes in CO from baseline.      
! Much of the past work comparing IT to MCT includes patients with a cardiac 
history. Warburton et al. showed that IT revealed higher functional performance versus 
MCT in patients with a history of CAD, revealing a significant greater improvement (p < 
0.05) in time to exhaustion. In a previous study, 14 men with a history of CAD (> 6 
months) who underwent bypass surgery or angioplasty were stratified by age, BMI, and 
VO2max (Warburton, et al., 2005). Subjects were randomized to a traditional cardiac 
rehab model consisting of MCT or an IT program. Both programs consisted of the same 
warm-up, standardized resistance training, and cool-down. The aerobic training in the 
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MCT consisted of 30 minutes of aerobic exercise at 65% of HR/VO2 reserve, while the 
IT program included 2 minute bouts of increased intensity at 90% HR/VO2 reserve 
followed by 2 minute recovery bouts at 40% HR/VO2 reserve. Both groups trained 30 
minutes per day, 2 days per week, for 16 weeks. Aerobic training involved 3 separate 10 
minute bouts on 3 different types of cardiovascular exercise equipment, for a total of 30 
minutes. It is important to note that a systematic review of patients with a history of CAD 
(range 4 weeks to 12 months post-MI) who performed interval training reported that no 
adverse cardiac events took place in 213 participants (180 men and 33 women) in 7 
separate studies (Cornish, Broadbent, & Cheema, 2010).
! Another randomized study with cardiac patients assessed IT versus MCT, for 
increasing VO2max (Rognmo, et al., 2004). Rognmo et al. studied 17 CAD patients (14 
men and 3 women) who had a past (> 12 months) coronary artery bypass graft or MI. 
Training consisted of treadmill walking 3 x per week, for 10 weeks. Total training load 
was equal, but the IT group exercised in 4 minute bouts of higher intensity, equal to 
85-95% peak HR (80-90% VO2 max) achieved on a baseline maximal cardiorespiratory 
exercise test on a treadmill. The IT group exercised at 50-60% VO2max during the 
remainder of each exercise session. The MCT group remained at 50-60% of VO2max for 
their entire exercise session. Total training load was balanced by the MCT group 
exercising longer than the IT cohort. The main outcome measure, VO2max, increased 
significantly more (p = 0.01) in the IT versus the MCT group after the 10 week 
intervention. The outcomes from sedentary and cardiac populations provide evidence 
that IT can be more effective for improving functional exercise capacity secondary to 
greater increases in CO and VO2max. 
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! Interval training has been effective at improving VO2peak significantly greater 
compared to MCT in supervised interventions for populations other than breast cancer 
survivors (Daussin, et al., 2008; Rognmo, et al., 2004; Tjonna, et al., 2008; Warburton, 
et al., 2005; Wisloff, et al., 2007). Yet, currently there has not been a study investigating 
the efficacy of IT in the home-based environment. The previous studies on IT provide a 
foundation for hypothesizing that IT may enhance cardiorespiratory fitness and improve 
health outcomes for breast cancer survivors. We aim to identify the feasibility of using 
IT and MCT during an Energy Balance Program (Aim 1) and determine the impact of 
cardiovascular exercise dosing on improving VO2max and weight loss while using IT and 
MCT dosing methodology (Aim 2).
1.7 Significance of Research
! Diet and exercise interventions have shown to improve CVD and breast cancer 
risk factors in breast cancer survivors. To our knowledge, no prior studies have 
examined the response to different cardiovascular exercise doses including IT during a 
home-base intervention in this high-risk population. This gap in the literature exists 
despite growing evidence supporting IT as an effective means to improve 
cardiorespiratory fitness in chronic diseases, including CVD. However, a scarcity of data 
is available in the field of cancer survivorship. 
! Results from this study can contribute to the current literature on the feasibility of 
cardiovascular exercise dose prescription for breast cancer survivors in a home-based 
study. This dissertation project will provide novel information on two different 
cardiovascular exercise dose intensities prescribed during a home-based intervention 
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for breast cancer survivors, while determining the impact on improving VO2max and 
weight loss. The work presented in the following chapters can serve as a foundation for 
further studies exploring the impact of IT on cardiorespiratory fitness in breast cancer 
survivors.   
 
1.8 Specific Aims and Statement of Hypotheses
! Breast cancer treatment can have adverse effects on lifestyle related risk factors 
including inactivity and body composition. Inactivity can serve as a precursor for low 
cardiorespiratory fitness and weight gain. Combined diet, exercise and lifestyle behavior 
modification (Energy Balance Program) may influence health related outcomes during 
breast cancer survivorship, what is not clear is the most effective exercise dose to elicit 
the greatest improvement in targeted risk factors during an Energy Balance 
Program.!
! This dissertation project was conducted to contribute to a need that was 
established from  preliminary work investigating cardiorespiratory fitness in breast 
cancer survivors. Initially, we determined that breast cancer survivors had a low 
cardiorespiratory fitness level when compared to age-matched healthy normal values; 
and submaximal testing on a treadmill and elliptical trainer had a strong correlation to 
the “gold standard” test for measuring cardiorespiratory fitness on a treadmill (Chapter 
2). The overarching goal of this project was to develop a clinically effective and feasible 
exercise strategy for improving in VO2max and weight loss during an Energy Balance 
Program for breast cancer survivors. The overall objective of this dissertation was to 
determine whether cardiovascular exercise dosing during an Energy Balance Program 
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is feasible and will have different effects on VO2max and weight loss. Our central 
hypothesis is that breast cancer survivors will be able to adhere to cardiovascular 
exercise dosing including MCT and IT; and IT will elicit greater improvements on VO2max 
and weight loss compared to MCT during an Energy Balance Program. The rationale for 
the proposed research is that, once the feasibility of cardiovascular exercise dosing is 
known, effective exercise prescription can be made for breast cancer survivors, 
resulting in an innovative approach to address cardiorespiratory fitness and weight loss. 
Two central aims guide this dissertation research:
  
Specific Aim # 1: Determine the feasibility of two separate exercise doses, IT and MCT, 
in breast cancer survivors while they participate in a 17-week Energy Balance Program 
(Chapter 3). 
! If breast cancer survivors can use exercise dosing prescription during an Energy 
Balance Program, then greater improvements in risk factors for CVD and breast cancer 
may occur. It was hypothesized that breast cancer survivors will be able to participate in 
exercise dosing using MCT and IT during an Energy Balance Program, as evidenced by 
adherence to prescribed exercise time and intensity. The results demonstrated that 
participants were able to adhere to their prescribed exercise dose time and intensity 
during an Energy Balance Program. These results suggest that exercise dosing can be 
used in an Energy Balance Program.
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Specific Aim # 2: Identify the impact of two separate cardiovascular exercise doses on 
improving VO2max and weight loss, comparing baseline to post-intervention values 
(Chapter 3). 
! Because no studies have previously examined the usefulness of cardiovascular 
exercise dose intensity during a home-based intervention, we aimed to compare mean 
within- and between-group changes in VO2max and weight after breast cancer survivors 
participated in an Energy Balance Program. We hypothesized that, if differences were 
identified, IT would elicit a more favorable response for improved VO2max versus MCT. 
Results showed that significant improvements occurred in VO2max and weight loss after 
a 17 week Energy Balance program using cardiovascular exercise dose prescription. 
Furthermore, IT elicited a significantly greater improvement in VO2max compared to MCT. 
Results suggest that IT can elicit greater improvements in VO2max than MCT for breast 
cancer survivors. 
! In summary, the research presented in this dissertation contributes to the field of 
breast cancer survivorship in two separate manuscripts. These manuscripts provide 
unanswered questions relating to important health outcomes for breast cancer 
survivors: 1) demonstrate cardiorespiratory fitness level in breast cancer survivors  
(Chapter 2, prepared for submission to Breast Cancer Research and Treatment, 2) 
submaximal exercise testing may be an alternative to maximal testing for objectively 
measuring cardiorespiratory fitness in breast cancer survivors (Chapter 2), 3) feasibility 
of cardiovascular exercise intensity dosing during an Energy Balance Program (Chapter 
3, to be submitted to Cancer Prevention Research), and 4) impact of cardiovascular 
exercise dosing on improving VO2max and weight loss (Chapter 3).
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Intervention group was 
more likely to report 
increased physical activity 
vs. the control group (p= 
0.036), but not diet 
changes. 





















of four newsletters 




consisted of 4-20 
minute calls over 
nine months.
Combined intervention 
produced the greatest 
changes in fruit and 
vegetable consumption, 
but this effect was seen in 
controls and not in 
colorectal cancer 
survivors. No changes in 
weight or physical activity 
were observed. 
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Table 1.1 ! Diet and Physical Activity Randomized Controlled Trials.
! ! Five randomized controlled trials of combined diet and physical activity 
! ! over a three year span (2007-2010). Modified from: (Peckmezi & Demark-
                      Wahnefried, 2011).



























greater than 30 
minutes of 
exercise per 








sessions over a six 
month period. 
Fat and fruit and vegetable 
scores differed 
significantly in the diet + 
exercise arm; though no 
differences in change 
scores were observed for 
physical activity.
























sessions. Goals = 
15 minutes strength 
training every other 
day, 30 minutes/
day endurance 
exercise, 7-9 fruits 
and vegetable 
servings per day.  
Physical activity, weight 
loss, dietary behaviors, 
and overall quality of life 
improved significantly in 
the intervention group 
compared with the control. 
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Six month program 
with groups 
meeting weekly for 
six weeks, bi-
weekly for one 
month, and monthly  
for three months, 
with calls or 
newsletters on 
weeks groups did 
not meet. Goal = 
aerobic activity five 
days/week for 45 
minutes or more 
and 5% weight 
loss.  
Intervention group showed 
significantly greater 
improvements in weight 
and physical activity than 
the control group (p-values 
<0.05).
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12 weeks of 
detraining.
Three sessions 
per week for 8 
weeks. 
(Supervised) 
Maximal oxygen uptake 
(Vo2max) increased after both 









assigned to an 





Two sessions per 




VO2 peak significantly 
improved in IT group (p<0.05) 
and MCT group (p<0.001) 
after the exercise program. 
There were no significant 







assigned to an 










Both groups significantly 
improved VO2 peak: (CT: 6% 
increase, P=0.01); (IT: 8% 
increase, P=0.01). 
Table 1.2 ! Interval Training Trials.
! ! Ten separate trials using interval training from the past decade. 
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Five sessions per 
week for 4 weeks. 
(Supervised 
rehabilitation) 
Followed by 6 
months of home-
based exercise. 
VO2 peak increased between 
baseline and 4 weeks in AIT 
(P < .001) and MCT (P < .
001); group difference was 
not significant after 4 weeks 
of supervised rehab.  VO2 
peak in AIT group significantly 
improved between 4 weeks 
and 6 months (P < .001), with 












Three week trial. 
(Supervised)
VO2 peak at the anaerobic 
threshold and at maximal 
exercise increased in the 
continuous exercise group: 
13.7% (p < 0.05) and 9.3% (p 
< 0.05). In the interval training 
group the increase was 14% 
(p < 0.05) and 8.1% (p < 
0.05).











Three times per 
week for 10 
weeks. 
(Supervised)
VO2 peak increased by 
17.9% (P=0.012) in the high 
intensity group and 7.9% 
(P=0.038) in the moderate 
intensity group. The training-
induced adaptation was 
significantly higher in the high 














(AIT) vs. control 
group.
Three times per 
week for 16 
weeks. 
(Supervised)
VO2 peak increased more 
after AIT than CME (35% 
versus 16%; P<0.01). 
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Two days per 
week for 16 
weeks. 
(Supervised)
Both groups significantly 
improved VO2 peak: 
(P<0.05), but no between-
group difference in degree of 
change. The interval training 
group showed a significantly 
greater improvement in VO2 
at anaerobic threshold 
compared to the traditional 
rehabilitation group  (P<0.05). 
















per week for 12 
weeks. 
(Supervised x 2 
per week and 1 x 
per week at home) 
VO2 peak increased more 
with AIT than MCT (46% 
versus 14%, P<0.001). 













Participants in the 
CTG and ITG 
groups performed 
3 training sessions 
per week for 7 
weeks. 
(Supervised) 
VO2 peak was significantly 
improved in CTG (+7%, p < 
0.001) and ITG (+4.8%, p < 
0.001), whereas no difference 






Figure 1.1 ! Modifiable Risk Factors that can Increase the Chance for Breast 
! ! Cancer and the Incidence of CVD
Modifiable Lifestyle Risk Factors
• Inactivity
• ↓ CR fitness (VO2 peak)
• ↑ weight (BMI ~ fat mass)
• ↑ Glucose
• ↑ Insulin
• dysregulation of Estradiol
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Figure 1.2! Breast Cancer Survivors Disease Prevention Model
! ! Conceptual model of the two leading causes of mortality in breast cancer 
! ! survivors and an intervention strategy to help prevent disease onset. The 
! ! Indirect and direct effects of the breast cancer treatment experience can 
! ! have a negative impact on survivors’ health outcomes. Home-based 
! ! combined diet and exercise interventions are proposed to improve 
! ! targeted risk factors.
! !
Chapter 2
Measurement of Cardiorespiratory Fitness in Breast Cancer Survivors
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2.1 Introduction
! More than 290,000 women were estimated to be diagnosed with breast cancer in 
2011, and the number of survivors has risen beyond 2.5 million (ACS, 2011). There is 
an excess risk of cardiovascular deaths in women with breast cancer which is the 
second most common cause of death in breast cancer survivors (Eloranta, et al., 2012). 
The excess in risk of cardiovascular death is likely due to physical inactivity and weight 
gain as well as side effects of treatment (Ewer, Swain, Cardinale, Fadol, & Suter, 2011; 
Jones, Haykowsky, Swartz, et al., 2007). Women with low cardiorespiratory fitness 
measured during a graded maximal exercise test and assessment of maximal oxygen 
consumption, or VO2max, have both an increased risk of cardiovascular and breast 
cancer deaths (Blair, et al., 1996; Blair, et al., 1989; Peel, et al., 2009). Women with low 
cardiorespiratory fitness (below VO2max of 8 METS or 28 mL.kg-1.min-1 VO2) had a nearly 
3 fold increase in beast cancer deaths compared to those who reached a level above 8 
METS (Peel, et al., 2009).
! Collectively, the double impact from the effects of lifestyle changes and breast 
cancer adjuvant treatment may increase the risk for late-onset CVD. Despite this 
knowledge, there is not a current stratification tool to accurately assess increased risk of 
CVD morbidity and mortality in breast cancer survivors. For example, sub-clinical 
cardiac dysfunction may go unnoticed until more overt symptoms occur and still remain 
undetected by a resting echocardiogram (ECHO) (Cardinale, et al., 2004; Civelli, et al., 
2006). However, exercise tests may be more sensitive than resting tests in identifying 
cardiac dysfunction in long-term survivors (Gottdiener, et al., 1981; Klewer, Goldberg, 
Donnerstein, Berg, & Hutter, 1992; Weesner, Bledsoe, Chauvenet, & Wofford, 1991). 
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Therefore, exercise testing may serve as an important clinical tool for identifying breast 
cancer survivors who are asymptomatic, but at increased risk for the development of 
CVD. Furthermore, cardiorespiratory exercise testing can provide an objective 
evaluation of cardiorespiratory fitness, reducing the variability found in self-reported 
activity measures by 70-80% (Blair & Church, 2004).  
! While a maximal exercise test is the gold standard for assessing cardiorespiratory 
fitness, a maximal cardiorespiratory exercise test requires participants to push 
themselves to volitional exhaustion and peak heart rate (HR) (ACSM, 2009). A maximal 
effort from the patient is usually confirmed based on various objective and subjective 
indicators including a; 1) plateau in heart rate and oxygen uptake with increased 
workload, 2) respiratory exchange ratio > 1.1, and 3) rating of perceived exertion > 17 
(ACSM, 2009). In contrast, submaximal testing allows for an estimated measure of 
sustainable cardiorespiratory exercise capacity (Wasserman K, Hansen J, & Sue D, 
1999). without maximizing heart rate. 
! Submaximal exercise testing has been used to provide a measure of 
cardiorespiratory fitness, with outcomes based on an end point at anaerobic threshold 
or 85% APMHR in patients with a history of congestive heart failure (Kemps, et al., 
2008), stroke (Eng, Dawson, & Chu, 2004), cancer (Carlson, Smith, Russell, Fibich, & 
Whittaker, 2006), and athletic populations (Bernardi, et al., 2010). Although there is not 
a standard submaximal treadmill protocol, an endpoint at a pre-determined 85% age 
predicted maximum heart rate may be used (ACSM, 2006; Taylor, et al., 2010). 
Submaximal exercise testing is less expensive than maximal testing in that it does not 
require physician presence during the test, and may be completed without expensive 
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equipment such as a metabolic cart. Submaximal testing is more feasible for use in de-
conditioned women who may discontinue a maximal test early because of fatigue, which 
is a complaint in 50-80% of breast cancer survivors who have undergone systemic 
therapy (Andrykowski, Curran, & Lightner, 1998; Gitt, et al., 2002). 
 A recent meta-analysis indicates a need for a standardized and objective measure 
of fitness which can be readily utilized in the breast cancer survivorship population 
(McNeely, et al., 2006). Accordingly, we investigated the association between the gold 
standard measure of cardiorespiratory fitness (VO2max) with different submaximal testing 
endpoints in breast cancer survivors. We hypothesized the VO2 at submaximal 
endpoints would be highly correlated with VO2max in breast cancer survivors. In addition, 
we aimed to demonstrate that breast cancer survivors would have a lower VO2max when 
compared to published normative data. A secondary analysis was to assess left 
ventricular ejection fraction (LVEF) in breast cancer survivors from measurement with 
an ECHO or multi gated acquisition scan (MUGA). Important clinical implications can 
arise from evaluating cardiorespiratory fitness in breast cancer survivors and targeting 
those in the greatest need of preventive measures.
2.2 Methods
 Objectives were to analyze VO2max and submaximal endpoints in breast cancer 
survivors who had been treated with adjuvant therapy. The submaximal tests utilized a 
treadmill and an Arc Trainer (Cybex Arc Trainer 750AT) for all cases in this study. Arc 
Trainers use a low-impact mechanical design with production of lower vertical forces 
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and joint loading compared to walking on a treadmill (Lu, Chien, & Chen, 2007; Turner, 
Williams, Williford, & Cordova, 2010). 
 The study was approved by the University of Kansas Medical Center Human 
Subjects Committee and written informed consent was obtained from all participants at 
an orientation meeting prior to conducting any study testing or activities.
Participants
 This was a cross-sectional study using a within-subject design to investigate the 
cardiorespiratory fitness and associations between submaximal and maximal 
cardiorespiratory tests in breast cancer survivors. A total of 30 breast cancer survivors 
were enrolled in the study. Recruitment was performed by the recruitment coordinator 
from follow-up clinics at the University of Kansas Breast Cancer Survivorship Center 
(BCSC). Inclusion criteria were as follows: previously diagnosed with stage I-IIIa breast 
cancer; ages 30-60; no evidence of metastatic disease; at least 3-months from 
completing initial chemotherapy and/or radiation therapy; within 10 years of initial 
diagnosis; and available results of a resting ECHO or MUGA prior to receiving initial 
chemotherapy. Subjects had to also have 2 of the following cardiac risk factors: body 
mass index (BMI) > 25 kg.m -2 , hypertension (systolic blood pressure > 140 mm Hg 
and/or diastolic blood pressure > 90 mm Hg) (ACSM, 2009), elevated low density 
lipoprotein (LDL) (fasting serum  level > 130 mg.dL -1) (NCEP, 2002), positive family 
history of  myocardial infarction, coronary revascularization, or sudden death in mother, 
father, or first-degree relative, sedentary lifestyle (not currently participating in habitual 
exercise of moderate to vigorous intensity for two or fewer sessions per week), smoker 
40
(currently smoking or quit smoking within the last six months); and 1 treatment-related 
risk factor: chemotherapy and/or left breast radiation. 
Outcomes 
 All study procedures were conducted during three testing sessions within a two 
week time frame at the Clinical Translational Science Unit (CTSU) on the University of 
Kansas Medical Center campus and the cardiovascular lab located at the University of 
Kansas Hospital. Participants were instructed to refrain from exercise 48 hours prior to 
maximal and submaximal cardiorespiratory testing. In addition, all participants were 
asked not to consume any food, caffeine, alcohol, and tobacco products three hours 
prior to exercise tests. The exercise testing sessions were between 2 and 14 days apart 
and at the same time of the day. All cardiorespiratory tests followed the American 
College of Sports Medicine (ACSM) guidelines for procedures during graded exercise 
testing (ACSM, 2009). In addition, the exercise testing sessions were at least 48 hours, 
but no more than 14 days, from the resting ECHO/MUGA. Data on demographic 
information and health history were obtained (Table 2.1).
 Other study measures. Blood pressure and resting heart rate was measured at 
rest prior to exercise testing. Family history of heart disease, hypertension, low-density 
lipoproteins, sedentary lifestyle, and smoking habits was assessed from the chart 
review, clinical interview, and self-report during initial screening for the study.
 Maximal treadmill test. Cardiorespiratory fitness was assessed using a modified 
Balke protocol (Balke B, 1959; Blair, et al., 1989). Tests were conducted by qualified 
personnel including an exercise physiologist, nurse, and CTSU medical monitor. An 
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integrated metabolic measurement system (Parvo Medics TrueOne 2400) was used for 
measurement of maximal oxygen consumption interfaced with an ECG system (Schiller 
AT-10 Cardiograph). The metabolic cart was set to produce a 15-second average of the 
data collected during gas analyses for all tests. Equipment was calibrated per 
manufacturers recommendation prior to testing. Participants were fitted and acclimated 
to a mouthpiece and headgear (Hans Rudolph; Shawnee, KS) before stepping on to the 
treadmill. Participants were encouraged to give a maximal effort during the test. The 
protocol involved 1 minute at 2.0 MPH, 1 minute at 2.7 MPH, and increased to 3.3 MPH 
and a grade of 1% at minute 3. The grade increased 1% each minute thereafter. 
Participants continued walking on the treadmill at increasing incline until exhaustion, 
unless indications for terminating the maximal test were observed (ACSM, 2009). 
Participants cooled-down at 1.5-2.0 MPH and a level grade for a period of two to five 
minutes. Expired air was analyzed for O2 and CO2. Heart rate, blood pressure, and 
rating of perceived exertion score were determined at the end of each two minute stage. 
Confirmation of a maximal effort was determined by meeting three out of four of the 
following criteria; 1) plateau in heart rate and oxygen uptake with increased workload, 2) 
respiratory exchange ratio > 1.1, 3) rating of perceived exertion > 17, and 4) heart rate > 
90% of age predicted maximal heart rate.
 Submaximal treadmill test. Cardiorespiratory fitness submaximal endpoints on the 
treadmill were determined by the VO2 at anaerobic threshold  and 85% age predicted 
maximum heart rate. Initial criteria for anaerobic threshold was established by using the 
respiratory exchange ratio > 1.0. Participants were allowed to continue for three 
consecutive 15 second averages at a respiratory exchange ratio  > 1.0 to ensure 
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anaerobic threshold was reached. Post-test confirmation of the anaerobic threshold was 
made upon visual assessment of 1) V-slope method, and 2) ventilatory equivalent 
technique to rule out hyperventilation. Submaximal VO2 at 85% age predicted maximum 
heart rate was assessed with the calculation [(220-age) x 0.85] and determination of the 
corresponding VO2 at that heart rate during maximal testing on the treadmill.
 Submaximal Arc (Cybex 750AT) test. After a brief familiarization trial followed by a 
short rest period, participants began the Arc submaximal test. Participants’ weight was 
input into the console before starting the test. The manual mode was used for testing, 
with initial workload set at a resistance level of 15. Participants were asked to maintain 
between 80-100 strides per minute and a level grade was used throughout the test. 
Workload was adjusted to allow a linear increase in heart rate (5-10 bpm) for each 
stage until subjects reached the anaerobic threshold endpoint for 3 consecutive 15 
second averages. Increased workload was performed manually by a gradual increase in 
wattage while adjusting resistance in two minute stages. Resistance at each two minute 
stage varied between participants to allow a steady increase in heart rate, and was 
adjusted by a 5-10 numerical increase on the Arc trainer console resistance key pad. 
The cardiorespiratory fitness submaximal endpoint on the Arc trainer was determined by 
the VO2 at anaerobic threshold. Criteria for anaerobic threshold was determined by the 
same method as the submaximal treadmill endpoint.
 Cardiorespiratory fitness (VO2max). Cardiorespiratory fitness was measured by the 
participants’ VO2max during the maximal treadmill test. Besides group mean, individual 
VO2max was compared to the normative VO2max value for healthy age-matched women.
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(2) We performed our maximal treadmill test with a similar Balke protocol that was used 
for determining normative VO2max values.
 Left ventricular ejection fraction. Resting LVEF was performed on all breast cancer 
survivors by either an ECHO or MUGA, depending on which cardiac function test the 
participant had prior to starting breast cancer treatment. Resting LVEF at time of study 
were compared to pre-treatment (baseline) measures. Cardiac function (LVEF) was 
assessed by a cardiologist not associated with the study.   
 Anthropometrics and body composition. Body weight was assessed to the nearest 
0.1 kg, using an electronic scale (Health o meter, Boca Raton, Fl). A stadiometer was 
used to measure height without shoes to the nearest 0.1 cm (SECA). Body composition 
was measured by dual-energy x-ray absorptiometry in the total body scanning mode 
with a Lunar Prodigy DXA machine (Lunar Corp., Madison, WI). Body mass index was 
calculated as the weight in kilograms divided by the height in meters squared (kg.m-2). 
        
Statistical Analysis
 Pre-formatted data collection forms and case report forms were used for both 
clinical and laboratory data. Study data was entered into an Excel data base by a 
trained data clerk not related to the study. Numbers and percentages were used to 
describe VO2max in breast cancer survivors compared to age and gender matched 
normative values. Distribution normality and was verified using the Shapiro-Wilk test 
and variance homogeniety was confirmed from a Levene’s test. After assumptions were 
met, an association between all submaximal VO2 endpoints and VO2max was examined 
using Pearson correlation coefficients. Correlations were categorized as 0.26 to 0.49 is 
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a low correlation, 0.50 to 0.69 is moderate, 0.70 to 0.89 is high, and 0.90 to 1.00 is very 
high as described by Munro et al. (Munro, 1993). All analyses were two-tailed with 
alpha =0.05, and performed with SPSS statistical software (version 15.0; SPSS Inc, 
Chicago, IL).   
   
2.3 Results
Participant Characteristics
 Participant characteristics and non-treatment CVD risk factors are listed in Table 
2.1. Mean age was 50.5 + 5.6 years, 29/30 were caucasion, 1/30 was Latino, and the 
group had an average elapsed time since diagnosis of 58 months. The most frequent 
non-treatment related risk factors were BMI > 25kg/m2 (83%), elevated LDL (66%), 
family history of heart disease (40%), and sedentary lifestyle (33%). Additionally, the 
group mean body fat % was 44.5 + 7.7%. Treatment related risk factors are listed in 
Table 2.2 28/30 (93%) of the breast cancer survivors were postmenopausal at time of 
study, while 20/30 (66%) of the women were treated with an aromatase inhibitor. A large 
majority (80%) of the women received either doxorubicin or epirubicin, 27% were 
treated with trastuzamab, and 40% had left chest radiation. Also, the group mean LVEF 
at time of study was 60.5 + 5%, which was significantly decreased (p = 0.02) from 63.2 
+ 5.7% at time of diagnosis and prior to treatment.
Adverse Events from Testing
 All 30 maximal and 30 submaximal cardiorespiratory tests were completed without 
any adverse events. During maximal testing twenty-eight of thirty participants met our 
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established criteria for a maximal effort as explained previously. Two of the participants 
discontinued the test secondary to a claustrophobic sensation related to the 
mouthpiece, fatigue, and/or shortness of breath. Symptoms were resolved by 
discontinuing the test and having the participants rest while monitoring all post-test 
vitals. Even though two participants discontinued the maximal test prior to reaching 
maximal criteria, both participants achieved > 85% APMHR on the treadmill and have 
been included in the analyses.
                   
Cardiorespiratory Fitness Levels
 Our analysis of cardiorespiratory fitness revealed that 21 out of 30 (70%) women 
measured below the 20th percentile for their age and gender matched normative VO2max 
values. When separating into specific age groups, 30-39, 40-49, 50-59, and 60-69 years 
there were 1/1(100%), 9/12 (75%), 10/15 (66%), and 1/2 (50%) breast cancer survivors 
respectively that measured below the 20th percentile for VO2max. All submaximal testing 
of VO2 endpoints showed a high correlation to the actual measured VO2max when 
comparing within subject results (Figure 2.1), and the VO2 at 85% age predicted 
maximum heart rate on the treadmill showed the highest correlation with VO2max. During 
our study three participants were unable to complete testing on the Arc trainer due to 
their inability to coordinate the movement between the lower and upper limbs 
simultaneously. Also, the Arc trainer produced significantly lower VO2 (p <0.001) and 
heart rate (p = 0.02) at anaerobic threshold versus the treadmill submaximal test (Table 
2.3).
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2.4 Discussion
 All cardiorespiratory fitness measures are listed in Table 2.3. In this cohort of 
breast cancer survivors with > 2 risk factors for CVD, 70% had low cardiorespiratory 
fitness measured by VO2max despite a mean time since diagnosis of over 4 years and a 
normal LVEF at time of study. These results suggest that they are at a higher risk of 
breast cancer and cardiovascular mortality (Blair, et al., 1996; Blair, et al., 1995; Peel, et 
al., 2009). Our results are similar to two earlier reports in breast cancer survivors, (one 
of which women had controlled hypertension), suggesting the majority of women with 
non-treatment related CVD risk factors have a lower VO2max compared to healthy 
women even with a concomitant normal LVEF (Jones, Haykowsky, Pituskin, et al., 2007; 
Tolentino, et al., 2010). Our study differs from the earlier studies since we used a similar 
VO2max protocol (Balke protocol) to the standardized treadmill test used for determining 
normative values rather than a cycle ergometer or Bruce protocol and we reported pre- 
and post-treatment LVEF.  
 Sub-maximal exercise testing with VO2 measured at the anaerobic threshold and 
85% APMHR has shown a good correlation with maximal exercise testing in individuals 
where a maximum test would be difficult because of disability or de-conditioning 
including those with congestive heart failure, stroke, or undergoing bone marrow 
transplant (Carlson, et al., 2006; Eng, et al., 2004; Kemps, et al., 2008). To our 
knowledge, this is the first study to investigate the association between maximal and 
submaximal cardiorespiratory fitness testing in breast cancer survivors.    
 The submaximal VO2 at 85% APMHR was used because this predetermined 
endpoint could eventually be performed without expensive gas analysis equipment and 
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can be more feasible than measuring anaerobic threshold when a large number of 
patients or subjects need to be tested. Overall, the submaximal VO2 endpoint at 85% 
APMHR showed the highest correlation to actual measured VO2max. In addition, the 
submaximal VO2 endpoint at 85% APMHR had a similar group mean HR and VO2 
compared to the anaerobic threshold endpoint. This is important to note since anaerobic 
threshold is a helpful indicator for determining fitness level and for measuring the effect 
of exercise training (Casaburi, 1994; Casaburi, et al., 1991). 
 This study suggests that a submaximal test using a modified Balke protocol with 
an endpoint set at 85% APMHR would be a feasible endpoint to use for a validation 
study with a maximal test. Therefore, a more practical submaximal test could be 
performed when the equipment and personnel needed to conduct directly measured 
oxygen uptake via indirect calorimetry are not available.  
 We are unaware of previous studies that have used an Arc trainer with decreased 
load bearing force as an exercise testing modality to examine cardiorespiratory fitness 
in breast cancer survivors, many of whom have age-related or aromatase inhibitor 
induced arthalgia and may prefer alternate forms of testing. Turner et al. showed that 
VO2max and time to attain VO2max were similar when comparing results between testing 
modalities including an Arc trainer and a treadmill in healthy adults (Turner, et al., 2010).  
Overall, we suggest that the benefit of using an Arc trainer does not outweigh difficulty 
with performing the required coordinated movements and lack of standard testing 
protocol. Currently, a validated exercise protocol is not available for use on an Arc 
Trainer. Also, It is important to note that there were no breast cancer survivors in our 
study that could not complete testing on the treadmill due to joint or muscle pain.
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2.5 Conclusion 
 This is the first study to investigate the association between the gold standard for 
cardiorespiratory fitness (VO2max) to submaximal VO2 tests in breast cancer survivors 
who had been treated with adjuvant therapy. The findings from this study indicate that 
the majority (70%) of breast cancer survivors with > 2 CVD risk factors had low 
cardiorespiratory fitness and submaximal testing on the treadmill is a feasible, objective 
measure of fitness that can be used in breast cancer survivors. A main limitation of this 
study included the sample size (n= 30), which was too small for a validation study. In 
addition our sample lacked racial diversity and a control group. 
 Future research should include a large enough group of breast cancer survivors 
for a study to validate a submaximal test. Since our study indicated the 85% APMHR 
had the highest correlation, a future study aimed at validating the use of this 
submaximal endpoint to a maximal test would be helpful. Rather than using healthy age 
predicted normal values, women who share similar CVD risk factors and are at high-risk 
for breast cancer but have not received treatment may be a more appropriate 
comparison group to investigate the effects of breast cancer treatment on 
cardiorespiratory fitness. In addition, novel approaches should be made to improve 




Table 2.1! Participant Demograhics and Non-Treatment Related Characteristics
Variable Breast Cancer Survivors (n = 30)
Age (y) 50.5 + 5.6 
Time since diagnosis (months) 58 + 27 
BMI (kg.m-2) 29.2 + 5.3 
Body fat (%) 44.5 + 7.7
Overweight (BMI > 25 kg.m-2) 25/30 (83%)
Hypertension 8/30 (27%)
↑ LDL 20/30 (66%)
Family history heart disease 12/30 (40%)
Sedentary lifestyle 10/30 (33%)
Smoker 1/30 (3%)
Note: BMI, body mass index; LDL, low density lipoprotein.
Table 2.2 ! Treatment Related Characteristics
Variable Breast Cancer Survivors (n = 30)
Current Aromatase Inhibitor 14/30 (47%)
Current Tamoxifen 1/30 (3%)
Past AI’s 4/30 (13%)




Left chest radiation 12/30 (40%)
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Table 2.3 ! Cardiorespiratory Outcomes
 
Variable  Breast Cancer Survivors (n = 30)
Maximal VO2 (mL.kg-1.min-1) 25.4 + 5.3
Maximal HR (bpm) 169 + 12 
VO2 at AT on treadmill (mL.kg-1.min-1) 20.5 + 4.3
VO2 at AT on Arc (mL.kg-1.min-1) 19.0 + 4.4
VO2 at 85% APMHR (mL.kg-1.min-1) 19.9 + 3.0
HR at AT on treadmill (bpm) 148 + 13 
HR at AT on Arc (bpm) 144 + 13 
HR at 85% APMHR (bpm) 144 + 5 
Predicted Maximal HR (bpm) 170 + 6
Predicted VO2- 85% APMHR (mL.kg-1.min-1) 24.5 + 7.2
Predicted VO2max (mL.kg-1.min-1) 34.5 + 8.8
Resting HR (bpm) 78 + 10 
Maximal O2 pulse (mL/beat) 11.5 + 1.5 
Pre-Treatment LVEF 63.2 + 5.7%
Study LVEF 60.5 + 5.0%
Note: HR, heart rate; AT, anaerobic threshold; APMHR, age predicted 
! maximal heart rate; LVEF, left ventricular ejection fraction.
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Figure 2.1! Association Between Submaximal and Maximal VO2!
! ! The association between maximal oxygen uptake with (A) treadmill 85% 




Cardiovascular Exercise Dose Intensity for Improving Cardiorespiratory Fitness 
in Breast Cancer Survivors
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3.1 Introduction 
! Early diagnosis and adjuvant therapies have been effective at increasing 
women's life span after breast cancer diagnosis. It is estimated that greater than 75% of 
breast cancer survivors will live ten years after diagnosis (NCI, SEER 1996-2007) and 
the number of breast cancer survivors exceeds 2.5 million(ACS, 2012). With this 
increased survival, many women may suffer from long-term effects of their diagnosis 
and treatment. Evidence shows that in addition to risk for recurrence, cancer survivors 
are at a greater risk than their non-cancer peers for developing secondary tumors and 
cardiovascular disease (CVD) (Demark-Wahnefried & Jones, 2008). Furthermore, a 
recent study suggested that the 10 year CVD risk estimate may exceed that of breast 
cancer recurrence (Bardia, et al., 2012); and showed that 80% of breast cancer 
survivors had a predicted CVD risk that was equal or greater than the breast cancer 
recurrence risk (Bardia, et al., 2012).
! It has been established that the treatment of breast cancer (adjuvant therapy, 
radiation, hormone therapy) may directly increase the risk of cardiac dysfunction 
(ASCO, 2007). In addition to these direct effects of treatment, the physical inactivity and 
weight gain may play an indirect role in cardiac dysfunction as well. Breast cancer 
survivors have reported decreasing their activity by an average of two hours per week 
or more based on their treatment regimen (Irwin, et al., 2003). Women with low 
cardiorespiratory fitness are at increased risk for all-cause mortality (Blair, et al., 1989) 
and breast cancer mortality (Peel, et al., 2009). A previous study demonstrated that the 
greatest impairment in cardiorespiratory fitness was associated with a worse CVD risk 
profile in breast cancer patients (Jones, Haykowsky, Pituskin, et al., 2007). However, 
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there is a paucity of data available for the effects of exercise training aimed at improving 
cardiorespiratory fitness, and ultimately, modifying CVD risk factors in breast cancer 
survivors.
! To further exacerbate the likelihood for poorer health outcomes, weight gain can 
result from adjuvant treatment for breast cancer or physical inactivity. Weight gain in 
breast cancer survivors has shown to significantly increase CVD mortality (Nichols, et 
al., 2009), with a 19% increase in CVD mortality associated with each 5-kg gain in 
weight after breast cancer. In addition, breast cancer survivors with a body mass index 
(BMI) greater than 25 kg/m2 have up to a 60% increased risk for death compared to 
survivors with normal body weight (Saxton, et al., 2006). A sedentary lifestyle can be 
seen as a precursor for the build-up of visceral fat, leading to an additional risk for CVD 
and tumorigenesis (Bird & Swain, 2008; Pedersen, 2009). Therefore, the potential for 
diet and exercise interventions to have a positive effect on targeted health outcomes in 
breast cancer survivors may have implications for long-term survival.     
! A few studies have demonstrated that physical activity interventions have been 
successful at improving cardiorespiratory fitness in breast cancer survivors (McNeely, et 
al., 2006; K. H. Schmitz, Holtzman, et al., 2005), and a recent review indicated that 
exercise interventions can improve fitness, physical function, and strength (Pekmezi & 
Demark-Wahnefried, 2011), while diet interventions can improve body weight, diet 
quality, and nutrition-related biomarkers (Pekmezi & Demark-Wahnefried, 2011). 
Furthermore, evidence points to a significant survival advantage for breast cancer 
survivors who engage in combined diet and exercise behavioral change versus exercise 
or diet alone (Pierce, et al., 2007). However, the cost of monitored and supervised 
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interventions and the demands on time and travel for cancer survivors are significant 
barriers to the implementation of these interventions (Pekmezi & Demark-Wahnefried, 
2011). Thus, there is a need to investigate home-based lifestyle interventions for cancer 
survivors as they may be more sustainable and applicable to the growing cancer 
survivor population.
! Diet and physical activity guidelines targeting cancer survivors have been issued 
by the American Cancer Society (ACS) and American College of Sports Medicine 
(ACSM) (Doyle, et al., 2006; K. H. Schmitz, et al., 2010). Despite these guidelines 
additional exercise trials are needed to explore the effects of different exercise 
prescriptions and dosing intensity (Neilson, et al., 2009). Additionally, more evidence is 
needed on the effects exercise interventions have on targeted outcomes of greatest 
need in cancer survivors. The purpose of our study was to investigate the effects of 
different cardiovascular dose intensities during a home-based diet and exercise 
intervention on targeted CVD and breast cancer risk factors in breast cancer survivors. 
Subjects participated in two different dose intensities, moderate continuous training 
(MCT) and interval training (IT). First, we hypothesized that breast cancer survivors 
would be able to adhere to MCT and IT during a home-based intervention. Specifically, 
we predicted that participants in both groups would achieve > 75% of their weekly 
prescribed cardiovascular exercise, without significant adverse events. Second, we 
hypothesized that IT would elicit greater improvements on selected CVD and breast 
cancer risk factors including weight loss and increased cardiorespiratory fitness 
(VO2max) versus MCT in breast cancer survivors. Lastly, we explored associations 
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between change in VO2max to  exercise time and intensity (average HR) downloaded 
from the HR monitors.       
 
3.2 Methods
! Study Design. This study used a cross-sectional design for baseline comparisons 
and within- and between-group design for analyzing repeated measures after an 
intervention. Participants were enrolled into two treatment groups receiving different 
levels of cardiovascular exercise dosing intensity, as depicted in Figure 3.1. The study 
was conducted at the University of Kansas Medical Center (KUMC). The Human 
Subjects Committee at KUMC approved all study procedures. Written informed consent 
was obtained from all participants at an orientation meeting prior to conducting any 
study testing or activities.    
! Recruitment and participants. A convenience sample of 19 women was recruited   
from the University of Kansas Breast Cancer Survivorship Center (BCSC) between 
November 2010 and October 2011. Recruitment was completed in two waves and 
performed by the recruitment coordinator from follow-up clinics at the BCSC. Flow of 
participants through the study is provided in Figure 3.2. The recruitment coordinator 
performed a chart review on patients currently enrolled in the BCSC data base to 
identify eligibility and placed a phone call to enroll participants into the study. The first 
group started the intervention in March 2011 and finished in July 2011, while the second 
group began in October 2011 and finished in February 2012. The first group (n =12) 
received moderate continuous training (MCT) and the second group (n = 7) was 
prescribed a higher intensity of cardiovascular exercise using interval training (IT).
57
! Study personnel obtained written permission from participants’ treating oncologist 
to perform all testing, diet, and exercise components of the intervention. To assess 
participants ability to safely perform exercise, a health history form was administred to 
all participants.  A lymphedema risk assessment self-care questionnaire and the 
Norman Lymphedema Survey was administered to all participants during initial 
screening to further rule-out possible diagnosis of lymphedema.
! Eligibility requirements included that participants had to: 1) be approved for 
participation in a diet and exercise program by their treating clinician, 2) have completed 
any intravenous therapy (chemotherapy) or radiation for > 8 weeks before starting the 
intervention, 3) have no evidence of metastatic disease, 4) be within 3 years of 
diagnosis of breast cancer and if on anti-hormonal therapy must have been on therapy 
for > 6 months, 4) be between ages 25-70, 5) have a BMI of 25-45 kg/m2, 6) be 
reasonably healthy with no medical conditions limiting trial participation, 7) be willing to 
participate in a structured diet/exercise/behavioral program requiring weekly group 
meetings in person, and 8) be at high risk for lymphedema (≥5 lymph nodes removed), 
with no history of lymphedema. Participants were excluded from the study if they met 
one of the following criteria: 1) breast cancer staged higher than IIIa, 2) medical status 
that would preclude safety of participation in a weight loss and exercise program, 3) on 
cardiac medications that would effect cardiac function, or 4) already enrolled in a weight 
loss program. 
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Diet and Exercise Intervention
! Resistance Training Education. An exercise physiologist met with participants 2 
times per week during the first month (weeks 1-4) of the intervention in groups of 2-6 
survivors to teach participants how to safely and effectively perform the resistance 
exercises, as seen in Figure 3.1. This education program was aimed at equipping the 
participants with the proper resistance training technique and form before starting 
training at home during week 5; and not on weight training. Adjustable weight dumbbells 
(PowerBlock, Owatonna, MN) were provided to the participants for the home-based 
intervention. Throughout weeks 1-4 all participants were taught proper form and 
technique for 2-4 resistance training exercises during each of the 8 visits. ROM and/or 
light weight (1-2 pounds) was used to effectively perform 15 repetitions with proper 
technique during the 1 month resistance education. Specific stretching exercises were 
taught to all participants for the purpose of warming-up and decreasing chance of injury 
prior to the resistance training. After stretching, all participants learned the proper 
technique for 3 core strengthening exercises to improve lower back and trunk 
stabilization that they would use when beginning the resistance training. Starting at 
week five all participants began the diet, combined exercise training (resistance/
cardiovascular), and weekly group meetings.
! Resistance Training Exercise. During weeks 5-8 all participants were instructed 
to perform 2 sets of 15 repetitions of each resistance exercise. Once 15 repetitions for 2 
sets was completed with proper technique and form for 2 consecutive resistance 
training sessions, participants increased weight. Weight was increased by 10% or 1 
pound, whichever was the least amount. Participants added a 3rd set of 15 repetitions 
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during weeks 9-17, as long as they could successfully complete their current weight for 
15 repetitions with safe technique. When participants were able to complete 3 sets of 15 
repetitions they could increase weight in small increments as previously described. 
Correct weight was selected to complete all repetitions with safe and proper technique. 
A second bout of stretching exercises concluded each resistance training session. A 
packet with pictures and order of all resistance, stretching, and core exercises was 
provided to all participants.
! Behavioral modification. All study participants took part in a behavioral 
modification program starting at week 5. Weekly one-hour sessions providing a group 
support system that facilitates weight loss included topics on nutrition, breast cancer 
and lifestyle, psychosocial issues and weight reduction. Sessions were led by a 
registered dietitian, clinical health psychologist, and an exercise physiologist who were 
trained to deliver the behavioral modification program. All sessions were delivered with 
pre-formatted print and visual materials. Participants were required to maintain a weekly 
diet and exercise log and weigh-in at each session. The diet consisted of 1200-1500 
calories per day. Daily recommendations consisted of 2 prepackaged meals (any brand 
<350 calories, <10g fat per meal) and 2 high whey-protein shakes (~150-180 calories, 
10g protein) participants purchased from their local grocery store, and >5 fruit and 
vegetable servings daily. 
! Cardiovascular Training Exercise: Cardiovascular exercise was delivered in the 
form of moderate continuous training (MCT) or interval training (IT). Participants in both 
groups were provided with, and instructed on the use of, a Garmin HR monitor (FR60) 
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to use during all cardiovascular exercise sessions. The exercise time and HR data was 
periodically downloaded for analysis by the exercise physiologist.  
! (MCT). After four weeks of resistance education, participants in this group were 
! instructed in a moderate intensity walking or exercise program. A moderate 
! exercise intensity was described as, ‘very easy to carry on a conversation while 
! exercising’. This program was prescribed according to “usual care” as delivered by 
! our oncology medical team. Therefore, no specific heart rate (HR) was prescribed. 
! Cardiovascular exercise included walking outside, on a treadmill, cycle ergometer, 
! or other activities. In addition, participants were prescribed a progressive increase 
! in cardiovascular exercise minutes, starting at week 5 with 60 minutes and 
! progressing to 75, 90, and 150 minutes of cardiovascular exercise during weeks 7, 
! 10, and 14, respectively. A minimum of 20 minutes per exercise session was 
! encouraged. 
! (IT). Participants in the IT group were prescribed the same moderate exercise 
! intensity with the same number of exercise minutes per week as the MCT group 
! during weeks 5-8, as seen in Figure 3.1. At the beginning of week 9 participants in 
! the IT group were provided an individually prescribed new target HR range to use 
! during IT bouts. The prescriptions were based on a HR range equal to 85-95% of 
! the maximal HR achieved during the baseline cardiorespiratory fitness test 
! (described in outcome measures below). Participants in the IT group were 
! instructed to incorporate an IT bout into their cardiovascular exercise sessions as 
! described in Table 3.1. Overall, time spent in the IT dose intensity was between 30 
61
! seconds to 5 minutes per interval and 2 minutes to 15 minutes per session (Table 
! 3.1). 
Outcomes 
! All baseline and 17-week outcomes were performed by the same testing staff on 
the same equipment. Measurement staff used scripts or were blinded to avoid biasing of 
results.  
! Maximal Cardiorespiratory Fitness (VO2max). Cardiorespiratory fitness was 
assessed using a modified Balke protocol (Balke B, 1959; Blair, et al., 1989). Tests were 
conducted by qualified personnel including an exercise physiologist, nurse, and medical 
monitor. An integrated metabolic measurement system (Parvo Medics TrueOne 2400) 
was used for measurement of maximal oxygen consumption interfaced with an ECG 
system (Schiller AT-10 Cardiograph). The metabolic cart was set to produce a 15-
second average of the data collected during gas analyses for all tests. Equipment was 
calibrated per manufacturers recommendation prior to testing. Blood pressure and 
resting HR was measured at rest prior to exercise testing. Participants were fitted and 
acclimated to a mouthpiece and headgear (Hans Rudolph; Shawnee, KS) before 
entering the treadmill. Participants were encouraged to give a maximal effort during the 
test. The protocol involved 1 minute at 2.0 MPH, 1 minute at 2.7 MPH, and increased to 
3.3 MPH and a grade of 1% at minute 3. The grade increased 1% each minute 
thereafter. Participants continued walking on the treadmill at increasing incline until 
exhaustion, unless indications for terminating the maximal test were observed (ACSM, 
2009). Participants cooled-down at 1.5-2.0 MPH and a level grade for a period of two to 
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five minutes. Expired air was analyzed for O2 and CO2. Heart rate, VO2, blood pressure, 
and RPE score were determined at the end of each stage. Confirmation of a maximal 
effort was determined by meeting three out of four of the following criteria; 1) plateau in 
heart HR and oxygen uptake with increased workload, 2) respiratory exchange ratio 
(RER) > 1.1, 3) rating of perceived exertion (RPE) > 17, and 4) HR > 90% of age 
predicted maximal HR.
 Body composition. Body weight was assessed to the nearest 0.1 kg, using an 
electronic scale (Health o meter, Boca Raton, Fl). A stadiometer was used to measure 
height without shoes to the nearest 0.1 cm (SECA). Body composition was measured 
by dual-energy x-ray absorptiometry in the total body scanning mode with a Lunar 
Prodigy DXA machine (Lunar Corp., Madison, WI). Body mass index was calculated as 
the weight in kilograms divided by the height in meters squared (kg.m-2). 
! Exercise adherence, exercise minutes, and exercise intensity. Participants turned-
in exercise logs during the weekly group meetings. If the exercise log was not turned in, 
the study coordinator contacted the participant by e-mail to remind them to send the log 
to the BCSC or bring to the next weekly group meeting. The exercise log included type 
of exercise, minutes spent on resistance training, minutes spent cardiovascular training, 
and any narrative for adverse events. Additionally, cardiovascular exercise time and 
intensity (heart rate) were collected by downloading each participants cardiovascular 
exercise data from their heart rate monitor on a periodic basis throughout the 
intervention.          
! Adverse events. Adverse events were collected during the intervention, as 
described by the NCI Common Toxicity Criteria, (version 4.2). Participants were 
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instructed to call the study coordinator if any adverse events occurred, regardless of 
whether the event was related to the study. In addition, the study coordinator asked 
participants, at weekly sessions, if any adverse events occurred during the previous 
week.
Statistical Analysis 
! Baseline characteristics of participants were compared between the two treatment 
groups using Student’s t-tests for continuous variables and Pearson’s Chi-square tests 
for categorical variables. Normality of outcomes was verified using the Shapiro-Wilk test 
and variance homogeniety was confirmed from a Levene’s test prior to analyzing 
baseline characteristics and within- and between-group comparisons. Due to a small 
sample size, non-parametric testing was used in some variables where normal 
distribution did not occur or unequal variance was present. Mann-Whitney U tests were 
substituted if assumptions for the t-test were violated or unable to be verified. All 
analyses were two-tailed with alpha = 0.05 and performed with SPSS statistical 
software (version 15.0; SPSS Inc, Chicago, IL).
! Exercise adherence was determined by average weekly exercise time achieved for 
the IT and MCT groups during the intervention. Subjects achieving greater than 75% of 
the prescribed time were considered adherent. Descriptive statistics including 
frequencies and percentages for categorical variables and means and standard 
deviations for continuous variables were used to report exercise adherence.  
Differences in the rate of adherence between groups were assessed using a chi-square 
test.  Additionally, self-reported cardiovascular training time, self-reported resistance 
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training time, average HR from Garmin data, cardiovascular training time from Garmin 
data, and nutritional intake (number of prepackaged meals, shakes, fruits and 
vegetables) were compared between groups using Student’s t-tests.
! Changes in body composition (weight, BMI, % fat mass, absolute fat mass, 
absolute mean mass) and cardiorespiratory fitness (VO2max) were tested for significance 
using paired Student’s t-tests. Wilcoxon signed ranks tests were substituted when 
assumptions for the t-test were violated or unable to be verified. 
! Comparisons were also made between the changes in body composition (weight, 
BMI, %fat mass, absolute fat mass, absolute lean mass) and cardiorespiratory fitness 
(VO2max) for participants in the IT group versus those in the MCT group. Again, two-
sample Student’s t-tests were used to identify significant differences in outcome 
measures. Mann-Whitney U tests were used if any assumptions were violated or unable 
to be verified.  
! Lastly, to explore if cardiovascular exercise dose intensity was associated with 
changes in VO2max, we analyzed cardiovascular exercise time and intensity downloaded 
from a heart rate monitor. Pearson correlation coefficients were used to assess bivariate 
associations between change in VO2max and cardiovascular exercise outcome variables 
from the heart rate monitor data (average HR and time). 
!     Normality of outcomes was verified using the Shapiro-Wilk test and variance 
homogeniety was confirmed from a Levene’s test prior to analyzing baseline 
characteristics and within- and between-group comparisons. All analyses were two-
tailed with alpha = 0.05 and performed with SPSS statistical software (version 15.0; 
SPSS Inc, Chicago, IL).  
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3.3 Results
! Figure 3.2 is a CONSORT diagram showing that 12 participants were enrolled into 
the MCT group and 7 into the IT group. Reasons for loss to follow-up included personal 
issues (n = 2) and flare-up of lymphedema (n = 1). One of the two participants with 
personal issues was able to complete part of the follow-up testing, but was unable 
schedule cardiorespiratory fitness testing. All three participants without complete follow-
up test results were from the MCT group.
! Table 3.2 describes the baseline characteristics of the 17 participants who 
completed pre- and post-intervention testing. No significant differences were noted in 
any baseline variables between groups. All women were post-menopausal at time of 
study and received chemotherapy and/or radiation during treatment. In addition, all 
women were currently taking tamoxifen or an aromatase inhibitor (AI) at time of study.
! Maximal Cardiorespiratory Fitness (VO2max). All participants were able to meet 3 
out of four criteria for achieving a maximal test at both time points. The IT group had a 
significantly greater increase for VO2max (p = 0.05) and duration on treadmill (p = 0.02) 
compared to the MCT group, as shown in Table 3.3. No significant between-group 
differences were noted for all other cardiorespiratory fitness testing outcomes. As seen 
in Table 3.3, significant within-group changes were noted for both groups in 
cardiorespiratory fitness testing measures including VO2max and duration on treadmill. 
Also, Table 3.3 indicates the P values for comparison of changes between the MCT and 
IT groups. Furthermore, analyses of individual change for VO2max for all participants are 
shown in Figure 3.3. The dotted line in Figure 3.3 represents a threshold VO2max of 
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28 mL.kg-1.min-1. Peel et al. showed an approximate 2.5 fold increase in death from breast 
cancer occurred in women with a previously measured cardiorespiratory fitness capacity  
below 8 METS, equal to a VO2max < 28 mL.kg-1.min-1 [1 metabolic equivalent (MET) = 3.5 
mL.kg-1.min-1] (Peel, et al., 2009). All participants in the IT group experienced an 
improvement in their VO2max. However, two participants in the MCT group had a 17 
week VO2max < their baseline measure.  
! Body composition. Table 3.4 shows the within- and between-group changes over 
the diet and exercise intervention for body composition. The results indicate there were 
significant changes across groups for all major body composition measures, except 
absolute lean mass (Table 3.4). Further analyses showed there were no significant 
between-group differences for change in body composition measures.
! Exercise adherence, exercise minutes, and exercise intensity. Self-reported 
adherence to the prescribed diet and exercise intervention was assessed from weekly 
diet and exercise logs, as seen in Table 3.5. The primary adherence outcome measure 
was defined as the number of participants in both groups who achieved > 75% of their 
weekly prescribed cardiovascular exercise. Both groups achieved > 75% of prescribed 
cardiovascular exercise time for each of the 13 weeks during the combined diet and 
exercise intervention, identified by self-report weekly logs. Adherence to the prescribed 
diet was similar in both groups, except for a significant difference between the MCT and 
IT groups in the average number of fruits and vegetables consumed each week (p < 
0.01). Furthermore, total cardiovascular training time and average HR were analyzed 
from data downloaded from the HR monitors. Total cardiovascular exercise time 
retrieved from the HR monitor compared to self-reports for the MCT and IT groups was 
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76% and 90% respectively. Downloaded cardiovascular exercise training time (average 
of total minutes per participant) was similar between the MCT and IT groups. However, 
cardiovascular training average HR was significantly higher for the IT group versus to 
the MCT (p = 0.03), as seen in Table 3.5. 
! Explorative analyses for associations between change in VO2max with 
cardiovascular exercise intensity (average HR) and time downloaded from the HR 
monitors were performed, as shown in Figures 3.4 and 3.5, respectively. Results 
indicated the IT group showed a significant (p < 0.05) and high correlation (r = 0.82) 
between VO2max with average HR, but not exercise time. No significant correlations 
were noted within the MCT group when analyzing association between VO2max and 
cardiovascular exercise time or average HR.
! Adverse events. Four participants in the MCT group and one in the IT group had 
AE’s unrelated to the study. All AE’s were identified as < 2 on a severity scale of 1-4, as 
described by the NCI Common Toxicity Criteria, (version 4.2). The only patient with an 
AE related to study procedures was a participant in the IT group who had asymptomatic 
premature ventricular contractions (PVC’s) during her baseline maximal 
cardiorespiratory exercise test. Follow-up was made with an onco-cardiologist to rule-
out any significant coronary artery disease.     
!                    
3.4 Discussion   
! To our knowledge, this is the first study to evaluate the effects of exercise dosing 
on CVD and breast cancer risk factors during a home-based diet and exercise 
intervention for breast cancer survivors. We found that both groups were able to 
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significantly improve body composition (weight, BMI, % body fat) and VO2max while 
adhering to their prescribed exercise time. Home-based interventions may favor 
sustainability versus strictly supervised programs (Pekmezi & Demark-Wahnefried, 
2011). Lifestyle change may be achieved as breast cancer survivors modify their 
behavior in an independent fashion during a home-based intervention. In addition, 
combined diet and exercise interventions can provide a meaningful survival advantage 
compared to diet or exercise alone (Pierce, et al., 2007). Our findings suggest that 
exercise dosing is feasible to prescribe in a home-based program using a combined diet 
and exercise intervention; and can have a positive impact on breast cancer and CVD 
risk factors including VO2max and weight loss and in breast cancer survivors. 
! The individual effect of diet and exercise alone must be considered when 
assessing the improvement of VO2max after combined interventions. Specific to our 
study, we must use caution when associating improved VO2max with cardiovascular 
exercise dosing without considering the impact a calorie restricted diet may have on 
improvement in cardiorespiratory fitness. Studies have assessed the improvement in 
VO2max when comparing diet or exercise alone versus diet plus exercise. In a recent 12-
week randomized intervention, obese participants were randomized to exercise only, 
calorie restriction only, or exercise and calorie restriction. The results indicated a 
significant increase in VO2max from the exercise alone or the combined exercise and 
calorie restriction intervention (14% and 18%, respectively), but found no change in 
VO2max in the calorie restriction alone group (Christiansen, et al., 2010). In a similar 6-
month intervention in overweight (non-cancer) participants, caloric restriction only versus 
caloric restriction plus aerobic exercise versus weight maintenance diet, VO2max 
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significantly improved (increased) in the caloric restriction plus aerobic exercise arm only, 
22+/-5% vs 7+/-5% (caloric restriction alone), vs -5+/-3% (weight maintenance diet) 
(Larson-Meyer, et al., 2010). Overall, interventions targeting cardiorespiratory fitness 
without exercise are not likely to significantly improve VO2max.
! To examine the effects cardiovascular exercise dose intensity has on CVD and 
breast cancer risk factors, we compared changes in VO2max and body composition 
between the MCT and IT groups. Our study showed a significant greater mean increase 
in change for both VO2max and duration on treadmill for the IT group when compared to 
the MCT group pre- to post-intervention. There were no further significant mean 
differences in change for CVD and breast cancer risk factors between the MCT and IT 
groups. Therefore, our study suggests that a group prescribed IT can improve VO2max 
significantly more than MCT during a home-based intervention for breast cancer 
survivors. 
! Clinical implications stem from improving VO2max, since increased 
cardiorespiratory fitness (measured as VO2max) has been associated with a decrease in 
all-cause mortality and CVD in  apparently healthy men and women. Each one 
metabolic equivalent [1 metabolic equivalent (MET) = 3.5 mL.kg-1.min-1] increase in VO2max 
corresponded to an 11-13% and 15-18% reduction of all-cause mortality and CVD 
respectively (Barlow, et al., 2012; Kodama, et al., 2009). In our study, the IT group 
experienced a 5.3 mL.kg-1.min-1 improvement, while the MCT saw a significantly lower 
improvement in VO2max at 2.3 mL.kg-1.min-1. Based on these previous results of Barlow et 
al. and Kodama et al., both groups were able to reduce their risk for all-cause mortality 
and CVD. Furthermore, our study led to significant improvements in cardiorespiratory 
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fitness for breast cancer survivors who are an increased risk for all-cause mortality and 
CVD compared to their non-cancer age matched peers.!       
! Previous studies indicate that a low predicted VO2max increases risk for CVD 
occurrence (Blair, et al., 1996) and breast cancer mortality (Peel, et al., 2009). 
Cardiorespiratory fitness was measured in a large group of healthy women. A linear 
trend (p = 0.007) was noted for an inverse relationship between breast cancer mortality 
and cardiorespiratory fitness (Peel, et al., 2009). Another study by Sui et al. determined 
a linear trend (p =0.03) for CVD incidence based on cardiorespiratory fitness in women 
with at least 2 CVD risk factors (Sui, LaMonte, & Blair, 2007). In Sui’s study there was 
an inverse relationship between predicted VO2max from a maximal treadmill test and 
CVD incidence. Based on these previous studies our findings may have implications for 
IT to improve a major CVD and breast cancer risk factor ~ VO2max. Additionally, results 
from this study indicate that prescribing IT may be safe and feasible in a home-based 
diet and exercise intervention. Specifically, the IT group was able to perform 
cardiovascular exercise at a significantly higher average HR compared to the MCT 
group without experiencing any AE’s related to the prescribed exercise intensity.
! It has been suggested that IT above 85% VO2max can contribute to both aerobic 
and anaerobic metabolic adaptations leading to more pronounced improvement of 
VO2max versus moderate intensity continuous exercise (Butcher & Jones, 2006; Cornish, 
et al., 2010; McArdle, 2007; Poole & Gaesser, 1985; Tabata, et al., 1996). Furthermore, 
IT at higher intensities has shown to be superior to continuous training at moderate 
levels for improving VO2max with sedentary (Daussin, et al., 2008), chronic obstructive 
pulmonary disease (Butcher & Jones, 2006), CAD (Cornish, et al., 2010), and athletic 
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(McArdle, 2007) populations. Even though we were not able to assess the proportion of 
time individuals spent within their prescribed IT intensity, our study indicated that 
exercise intensity (average HR) had a high correlation to an increase in VO2max within 
the IT group.
! Adherence was similar across groups for all diet and exercise variables 
measured by self-report, except for the amount of fruits and vegetables consumed. 
Additionally, both groups had similar total cardiovascular exercise time as measured by 
heart rate monitors. However, the IT group showed a significant greater average HR 
during cardiovascular exercise training when compared to the MCT group, measured by 
heart rate monitors. Explanations for the significantly higher HR may include the 
differing cardiovascular exercise prescription favoring a higher target HR in the IT group.
! This study has two main limitations. A larger sample size and a randomized 
controlled design will help determine the effects of cardiovascular exercise dosing. Our 
future work will include a larger sample size and a randomized design so that 
meaningful comparisons can be made between the MCT and IT groups for outcomes 
related to body composition and cardiorespiratory fitness. Therefore, the results from 
this study may provide the groundwork for additional trials. Future exercise interventions 
in breast cancer survivors should include cardiovascular exercise dose intensity to help 
establish the effectiveness of IT on cardiorespiratory fitness. Further sophisticated 
analysis of heart rate during IT bouts should be performed in order to more precisely 
evaluate time spent in the prescribed IT heart rate zone. If we can quantify the 
proportion of time participants exercise in their prescribed IT heart rate zone, we may 
conclude that prescribed IT heart rate zones are adhered to. Therefore, providing us a 
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more robust conclusion on IT’s association to improving VO2max greater than MCT.   A 
larger multi-center randomized controlled trial will be useful for determining exercise 
intensity dosing impact on breast cancer survivors in a home-based intervention. Also, it 
can be useful to increase the time of the RCT and include a long-term follow-up phase 
to assess sustained lifestyle change. Finally, 5-10 year longitudinal studies are needed 
to investigate the effect of a combined diet and exercise home-based intervention on 
CVD and secondary breast cancer risk. More work is needed in order to establish the 
optimal exercise dose to elicit the greatest improvement in CVD and breast cancer risk 
factors in breast cancer survivors.
3.5 Conclusion  
! In conclusion, the IT group was able to produce a higher average heart rate 
versus the MCT group during their prescribed cardiovascular exercise. In addition, 
increased change in VO2max was significantly correlated with average heart rate during 
cardiovascular exercise in the IT. Prescribing cardiovascular exercise dosing during a 
home-based diet and exercise intervention appears to be feasible and safe for breast 
cancer survivors. Additionally, the IT group produced significantly greater mean change 
in VO2max than the MCT group during our study. Including IT into exercise and 
rehabilitation programs may promote improvements in cardiorespiratory fitness, while 
decreasing the risk of CVD and possibly breast cancer recurrence. This study highlights 
the need for future research to examine the effect exercise dosing has on CVD and 




Table 3.1! Interval Training Prescription Timeline
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Table 3.2! Baseline Characteristics of Breast Cancer Survivors 
                      [Mean (SD) or n (%)]
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Table 3.3! Cardiorespiratory Fitness Pre- and Post-Intervention [Mean (SD)]
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Table 3.4! Body Composition Pre- and Post-Intervention [Mean (SD)]
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Table 3.5! Participant Adherence to Exercise Intervention [Mean (SD)]
Variable MCT (n = 10) IT (n = 7) P =
Cardiovascular exercise 
minutes (overall weekly 
average)
121.1 (29.5) 105.0 (24.1) 0.14
Resistance Training 
exercise (overall weekly 
average)
62.4 (14.0) 69.9 (12.6) 0.17
Cardiovascular exercise 
(Total Garmin minutes) 1200.1 (875.0) 1233.0 (879.0) 0.95
Average HR            (Total 
Garmin minutes) 118.4 (8.9) 130.2 (8.9) 0.03
*
Variables from self-reported weekly diet and exercise logs.  Also, inclusion of cardiovascular 
exercise minutes and average HR were included from Garmin. Significant difference: *p < 
0.05; **p < 0.01.
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Figure 3.1! Study Schema
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Figure 3.2! Flow of Participants Through Study
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Figure 3.3! Individual Change in VO2max (mL.kg-1.min-1). 
! ! Horizontal dotted line represents 28 mL.kg-1.min-1.
  !
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Figure 3.4! Association Between VO2max and Cardiovascular Exercise Intensity 
! ! (average HR) Retrieved from HR Monitor.
Figure 3.5! Association Between VO2max and Cardiovascular Exercise Time 






! The overarching goal of this dissertation research was to add to the limited 
existing knowledge in the literature relevant to exercise interventions for breast cancer 
survivors. Initially, we determined that a majority of breast cancer survivors in our study 
have a low VO2max compared to to their age-matched healthy normal values. Also, we 
identified that submaximal treadmill testing may be used as a future objective measure 
for cardiorespiratory fitness, which could be used in a variety of clinical settings for 
breast cancer survivors. Moreover, our findings support a home-based combined diet 
and exercise intervention for improving weight and VO2max in breast cancer survivors. 
Lastly, the results of our novel investigations suggest that IT elicited significantly greater 
improvements in VO2max versus moderate exercise intensity.
Chapter 2     
! The work associated with Chapter 2 provides knowledge about cardiorespiratory 
fitness assessment for breast cancer survivors. An objective measure of 
cardiorespiratory fitness has been lacking in the field of breast cancer. We determined 
that 70% of the thirty breast cancer survivors we performed a maximal cardiorespiratory 
test on had a low cardiorespiratory fitness level. Low cardiorespiratory fitness in breast 
cancer survivors may be due to direct treatment effects, indirect effects of lifestyle 
change, or a combination of both. Much work is needed to determine the moderating 
effects different breast cancer treatment regimens have on cardiorespiratory fitness. 
Also, more studies will be useful for gathering data on subsequent change in activity 
levels and cardiorespiratory fitness pre- to post-treatment for breast cancer. More 
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knowledge about the factors associated with changes in cardiorespiratory fitness may 
help identify women who may benefit the most for exercise training to improve 
cardiorespiratory fitness. 
! A major reason why cardiorespiratory fitness has not been measured from an 
objective test is due to the cost of equipment and staff required to perform maximal 
cardiorespiratory testing. In response to this barrier, we showed that sub-maximal tests 
strongly correlate with the gold-standard maximal test for measuring cardiorespiratory 
fitness in breast cancer survivors. Furthermore, we determined that submaximal VO2 at 
an endpoint based on HR had the strongest correlation. More work will be helpful in 
validating a submaximal VO2 test to a maximal test. After a robust validation study is 
completed, we may be able to use a submaximal test that does not require gas analysis 
and uses the 85% APHRM endpoint, which can be used in breast cancer survivors.    
! Clinical implications from Chapter 2 suggest that breast cancer survivors may 
benefit from a cardiorespiratory fitness assessment. Additionally, the results from 
Chapter 2 showed that a submaximal treadmill test that used 85% APHRM had the 
strongest correlation of the two modalities and three submaximal endpoints. Therefore, 
a study adequately powered to validate a submaximal test using the 85% APMHR may 
be considered to provide an objective measure of fitness in breast cancer survivors.   
Chapter 3
! The findings from the research in Chapter 3 expand on the body of knowledge in 
exercise interventions for breast cancer survivors. Exercise interventions using 
combined diet and exercise appear to produce greater improvements in CVD and 
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breast cancer risk factors versus diet or exercise alone. Breast cancer survivors desire 
home-based interventions and this preference may improve sustainability for creating 
life-style behavior modification. However, there is a paucity of data to indicate that 
home-based interventions are feasible to produce meaningful improvement in targeted 
outcomes. In order to add to the gap in the literature concerning home-based 
interventions, we conducted this study to determine the feasibility of a combined diet 
and exercise intervention using a home-based design. 
! In addition, this study provides knowledge to an existing gap in the literature 
relating to exercise interventions for breast cancer survivors. Specifically, it’s unknown if 
IT can provide a greater impact for improving weight loss or increased VO2max compared 
to moderate exercise intensity, until the completion of this novel study. Our results 
suggest that participants prescribed IT can achieve significantly greater improvements 
in VO2max versus MCT. Moreover, our study used IT in a home-based study without any 
adverse advents directly related to the increased cardiovascular exercise dose. 
However, more studies are needed before conclusions can be made about the most 
effective exercise strategy for breast cancer survivors. The knowledge gained in this 
study can be used as exercise methodology in a multi-center randomized design aimed 
at improving an important CVD and breast cancer risk factor ~ VO2max. Therefore, the 
collection of information relating to IT from this study and future work may eventually aid 




General Limitations of this Dissertation
! Most, if not all, projects must overcome certain inherent limitations and obstacles 
during the lifetime of the study. This dissertation had unique challenges since it was 
integrated with a pre-established behavioral modification program led by a 
multidisciplinary team including a health behavioral psychologist and a registered 
dietician. Although, the integration of the exercise dosing methodology into existing diet 
and exercise protocols produced unique challenges, the knowledge I gained from the 
dissertation was invaluable. Working side-by-side with a dietician and health behavioral 
psychologist provided a rich educational experience. This learning environment allowed 
additional tools to be added to my existing clinical toolbox for the development of future 
treatment strategies. The following limitations, clinical implications, and future directions 
will include certain study characteristics related to combining my dissertation with an 
existing program. 
Cardiorespiratory Fitness in Breast Cancer Survivors
!  Although we used the “gold standard” measure for cardiorespiratory fitness 
(VO2max), we did not use a control group for comparison to our group of breast cancer 
survivors. A control group of women at high-risk for breast cancer with a similar CVD 
risk profile could have been a better comparison group to breast cancer survivors 
versus healthy female normative values for assessing cardiorespiratory fitness in 
Chapter 2. Also, additional analyses of cardiorespiratory fitness in women at high-risk 
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for breast cancer may detect a need for early intervention to improve fitness in this 
population.
! Our study (Chapter 3) did not use a sedentary control group to evaluate the 
comparison of our Energy Balance Program to individuals not participating in a diet and 
exercise intervention. Because weight loss and improved cardiorespiratory fitness has 
shown to improve health outcomes for breast cancer survivors, we felt it was important 
to involve all participants in an intervention to improve their weight and cardiorespiratory  
fitness.        
!  
Association of Submaximal and Maximal Cardiorespiratory Tests
! Although VO2 at an endpoint based on HR had the strongest correlation in 
Chapter 2, more work should be performed to suggest a valid test for breast cancer 
survivors. A validation study will allow a more powerful conclusion for the use of a 
submaximal test as a surrogate to a maximal cardiorespiratory test. 
! Breast cancer survivors report observationally that they prefer stationary exercise 
equipment similar to an elliptical trainer. This preference initiated a desire by the our 
study team for assessing cardiorespiratory fitness on an Arc Trainer. However, we were 
limited in our ability to design a standardized exercise testing protocol while using an 
Arc Trainer as a modality to analyze submaximal VO2 (Chapter 2). Although we 
manually adjusted the workload to allow a gradual and linear increase in HR and VO2, a 
standardized protocol was not used for all subjects. A study to assess physiological 
responses to an Arc Trainer will be helpful for determining an accurate testing protocol, 
if future work is performed using this equipment modality.   
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Small Sample Size!
!  A larger sample of breast cancer survivors in Chapter 3 that could have been 
randomly assigned to a MCT or IT group would have provided a better generalization of 
the entire population of breast cancer survivors. It is reported that 62% of breast cancer 
survivors are overweight (Irwin, et al., 2005) and 36% are sedentary (Jones, et al., 
2004), while the average age of a breast cancer survivor is 61 (Hayat, et al., 2007). 
Participants across both groups in Chapter 3 were generally inactive 12/17 (71%), all 
overweight/obese and the average age was 53. It is possible that only highly motivated 
breast cancer survivors agreed to participate in the intervention. Therefore, 
improvements in risk factors found in our study can only suggest that the entire 
population of breast cancer survivors can see the same positive changes in 
cardiorespiratory fitness and body composition measures. 
! Furthermore, women who were > 3 years from initial diagnosis of breast cancer 
were excluded from the home-based diet and exercise intervention in Chapter 3. There 
is evidence suggesting that cardiac function abnormalities may increase over time after 
being treated with cardiotoxic chemotherapy agents (Shan, et al., 1996). Thus, if a more 
heterogeneous group of breast cancer survivors that included women up to 10 years 
post-diagnosis are studied, it is possible they may have a more profound decline in 
cardiorespiratory fitness. In summary, we may want to consider demographics, 
treatment regimen, stage of tumor, lifestyle-related characteristics, and time since 
diagnosis in future randomized controlled trials with a robust sample size in order to 
study a group of women who are as representative as possible of the entire breast 
cancer survivor population.
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Data Reporting During Home-Based Study
! Even though it may be a challenge for breast cancer survivors to consistently 
participate in exercise routines away from home due to time and travel, supervised 
exercise programs provide a more easily controlled setting for participants. A highly 
supervised exercise setting may help assure that participants comply with the 
prescribed exercise time and intensity. However, for the positive effects of exercise 
training programs to remain sustainable, we should consider the preference of breast 
cancer survivors to perform exercise in their home environment versus visiting a facility 
away from home (Jones & Courneya, 2002; Rogers, et al., 2007; Rogers, et al., 2009). 
Therefore, this dissertation used a home-based model for an exercise intervention. 
More work is needed to determine if the gains in cardiorespiratory fitness are 
sustainable for two to five years after initiating home-based interventions.   
! We collected total time in minutes and HR during cardiovascular exercise. 
However, as previously mentioned, data downloaded from the HR monitors for the 
MCT and IT groups was 76% and 90% of total exercise time collected by self report. 
While a HR monitor will allow reliable exercise data, even the simplest devices can be a 
challenge for users. Nonetheless, exploring monitoring devices that can provide the 
greatest opportunity to collect the most data from study participants will be helpful for 
future trials. 
! We did not evaluate volume of cardiovascular exercise (time x intensity) to 
calculate metabolic equivalents (METs) for comparison between groups. We would have 
needed to capture the approximate speed of the various types of activities the 
participants performed in order to quantify an accurate estimation of METs per week of 
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exercise for both groups. However, we did identify that the MCT group performed more 
average minutes per week of cardiovascular exercise compared the IT group. On the 
other hand, the IT group reported a significantly higher average HR based on the total 
minutes collected from the HR monitor. Although we can not discern an estimated METs 
per week of exercise, we can suggest that the IT group, on average, exercised less per 
week with a higher corresponding HR. 
Cardiorespiratory Fitness and Weight Training
! All participants performed light resistance training as part of the existing Energy 
Balance Program. The addition of resistance training may have had a moderating effect 
on cardiorespiratory fitness. It has been reported that VO2max significantly improved in a 
group of post-menopausal women performing high-intensity weight training alone 
(Brentano, et al., 2008). However, another study on heart failure patients reported a 
greater mean increase in VO2max in an aerobic training group versus the aerobic plus 
resistance training group (Mandic, et al., 2009). Although, a resistance training protocol 
was used for the dissertation, the strength training was very light and the average 
weekly self-reported minutes was similar between groups. More work is needed to 
investigate the effect combined cardiovascular and resistance training has on targeted 
outcomes in breast cancer survivors including body composition and cardiorespiratory 
fitness. Studies that use cardiovascular training, weight training, or combined 
cardiovascular / weight training will add to our knowledge on cardiorespiratory and 
musculoskeletal fitness in breast cancer survivors. 
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Cardiorespiratory Fitness in Combined Versus Diet or Exercise Alone Interventions
! The individual effect of diet and exercise alone must be considered when 
assessing the improvement of VO2max after combined interventions. Specific to our 
study, we must use caution when associating improved VO2max with an exercise 
intervention without considering the impact a calorie restricted diet may have on 
improvement in cardiorespiratory fitness. Is it possible to achieve significant improvement 
in VO2max with weight loss alone or is exercise required to achieve this goal? Studies have 
been undertaken to address this question, but non include a cancer population. In a 
recent 12-week randomized intervention, obese participants were randomized to exercise 
only, calorie restriction only, or exercise and calorie restriction. The results indicated a 
significant increase in VO2max from the exercise alone or the combined exercise and 
calorie restriction intervention (14% and 18%, respectively), but found no change in 
VO2max in the calorie restriction alone group (Christiansen, et al., 2010). In a similar 6-
month intervention in overweight (non-cancer) participants, caloric restriction only versus 
caloric restriction plus aerobic exercise versus weight maintenance diet, V02max 
significantly improved (increased) in the caloric restriction plus aerobic exercise arm only, 
22+/-5% vs 7+/-5% (caloric restriction alone), vs -5+/-3% (weight maintenance diet) 
(Larson-Meyer, et al., 2010). Overall, interventions targeting cardiorespiratory fitness 
without exercise may not lead to significant improvements VO2max.   
                 !      !
4.3 Clinical Significance and Future Directions
! The primary purpose of this dissertation research was to determine the effect of a 
home-based combined diet and exercise intervention (Energy Balance Program) on 
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VO2max and weight loss in breast cancer survivors. In addition, we used an exercise 
training strategy for determining the effects of IT on VO2max and weight loss in breast 
cancer survivors. The results demonstrated that an Energy Balance Program was 
feasible and could significantly improve VO2max and body composition in breast cancer 
survivors. Furthermore, the results of this research demonstrated that participants 
prescribed IT had a significantly greater increase in VO2max versus MCT.
! This dissertation work can have clinical implications, since increasing 
cardiorespiratory fitness (measured as VO2max) has been associated with a decrease in 
all-cause mortality and CVD in  apparently healthy men and women. Each one 
metabolic equivalent [1 metabolic equivalent (MET) = 3.5 mL.kg-1.min-1] increase in VO2max 
corresponded to an 11-13% and 15-18% reduction of all-cause mortality and CVD 
respectively (Barlow, et al., 2012; Kodama, et al., 2009). In our study, the IT group 
experienced a 5.3 mL.kg-1.min-1 improvement, while the MCT saw a significantly lower 
improvement in VO2max at 2.3 mL.kg-1.min-1. Based on these previous results of Barlow et 
al. and Kodama et al., both groups were able to reduce their risk for all-cause mortality 
and CVD. Furthermore, our study led to significant improvements in cardiorespiratory 
fitness for breast cancer survivors who are high-risk for all-cause mortality and CVD 
compared to their non-cancer age matched peers.           !
! This dissertation research has laid the groundwork for novel diet and exercise 
interventions for breast cancer survivors. A future goal of this research is to better 
understand the most effective cardiovascular exercise dose to elicit the greatest 
improvement in cardiorespiratory fitness and body composition in breast cancer 
survivors. Additionally, we would like to determine how to create sustainability into 
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cancer survivors life-style behavior so the positive effects of interventions impact long-
term health outcomes. Therefore, the collective integration of the current literature and 
the results from this dissertation provide direction for future research.
!
Integration of a Novel Exercise Prescription Into an Existing Program
! Exercise training has been suggested by clinicians for several years due to the 
benefits to cellular and functional systems. However, as clinicians, we are challenged 
with changing human behavior for successfully implementing long-term lifestyle change.  
Even though this dissertation work faced some challenges, the experience has led to a 
better all-around clinical view on cancer survivorship care, especially when considering 
the health behavior aspect of life-style modification. Observationally, women reported it 
would be difficult to find the time for travel to supervised exercise sessions on a regular 
basis. Also, the breast cancer survivors in our study commented they would be less 
comfortable exercising around people in a fitness facility. Therefore, we should consider 
future studies that focus on participant preferences for the environment that allows the 
best chance for sustainable improvements in health outcomes.
! Exercise variety may influence the compliance of long-term behavior modification 
for breast cancer survivors. It’s been shown that children prefer shorter bouts of high-
intensity exercise that resembles play compared to longer distance moderate exercise 
(Barkley, Epstein, & Roemmich, 2009). As adults, are we not similar to children when it 
comes to boredom with exercise? Women in the IT group also commented that their 
prescribed HR range provided a motivational tool which kept them engaged in the 
cardiovascular exercise. Lastly, participants in both the MCT and IT groups voiced their 
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concern about the resistance training protocol. Specifically, the resistance training 
protocol was too long and the participants lost interest in completing the prescribed 
resistance exercises. As a result of the observations noted, we should consider future 
interventions that include exercise regimens that have a chance to maintain motivation 
in order to achieve long-term behavior modification. A creative mix of resistance and 
endurance exercises may provide an ongoing cardiovascular workout that may aid in 
motivation and have a moderating effect on improved lean mass and cardiorespiratory 
fitness.
!     
Home-based Diet and Exercise Interventions
! As previously stated in Chapter 3, some evidence points to a significant survival 
advantage for breast cancer survivors who engage in combined diet and exercise 
behavioral change versus exercise or diet alone (Pierce, et al., 2007). Many 
interventions for breast cancer survivors can be delivered in a highly supervised 
environment and require patients to attend 2-3 sessions per week. However, the cost of 
monitored and supervised interventions and the demands on time and travel for cancer 
survivors may be significant barriers to the implementation of these interventions 
(Pekmezi & Demark-Wahnefried, 2011). Therefore, Pekmezi et al. indicated there is a 
need to investigate home-based lifestyle interventions for cancer survivors as they may 
be more sustainable and applicable to the growing cancer survivor population (Pekmezi 
& Demark-Wahnefried, 2011). As a result it seems like a natural progression from highly 
supervised interventions to home-based programs that may favor sustainable life-style 
behavior modification. Lastly, disseminating interventions to a large number of breast 
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cancer survivors is important in order to have a meaningful impact. In response to these 
issues concerning sustainability and dissemination, we are currently preparing a 
proposal, based on this dissertation data, for a National Cancer Institute supported 
study. We plan to lead a multi-center RCT using a home-based combined diet and 




! Emerging evidence suggests that poor cardiorespiratory fitness may play an 
important role in the the late adverse effects after breast cancer treatment including 
cardiac dysfunction and a worse CVD risk profile (Jones, Haykowsky, Peddle, et al., 
2007; Jones, Haykowsky, Pituskin, et al., 2007). Despite the impact cardiorespiratory 
fitness may have on breast cancer outcomes after diagnosis, survivors still have a low 
cardiorespiratory fitness level. Our work (Chapters 2 and 3) demonstrated the majority 
of breast cancer survivors have a significantly lower VO2max compared to age-matched 
normative values. Additionally, a recent study indicated that breast cancer survivors 
have a significantly lower VO2max compared to age-matched healthy controls (Jones, 
Haykowsky, Pituskin, et al., 2007). The reason for a low cardiorespiratory fitness level 
remains unclear, but cardiotoxic treatment agents and inactivity are thought to 
collectively contribute to an impairment in oxygen delivery and utilization (Jones, 
Haykowsky, Swartz, et al., 2007).
! Previous studies have demonstrated that physical activity interventions have 
been successful at improving cardiorespiratory fitness in breast cancer survivors 
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(McNeely, et al., 2006; K. H. Schmitz, Holtzman, et al., 2005), However, additional 
exercise trials are needed to explore the effects of different exercise prescriptions and 
dosing intensity in breast cancer survivors (Neilson, et al., 2009). Cardiovascular 
exercise dosing intensity has been used in other populations. For example, IT at higher 
intensities has shown to be superior to continuous training at moderate levels for 
improving VO2max with sedentary (Daussin, et al., 2008), chronic obstructive pulmonary 
disease (Butcher & Jones, 2006), CAD (Cornish, et al., 2010), and athletic (McArdle, 
2007) populations. Therefore, it seems logical to investigate the effects of IT during a 
home-based combined diet and exercise intervention for breast cancer survivors. 
Additionally, a better understanding of the ability to disseminate IT methodology to a 
larger number of breast cancer survivors will contribute to the field of breast cancer 
survivorship.
4.4 Conclusion
! The collection of research conducted and presented in this dissertation has 
established new information that may impact health outcomes for breast cancer 
survivors. A novel cardiovascular exercise training strategy was incorporated into a 
home-based intervention that may be disseminated to a large number of breast cancer 
survivors. Clinicians may consider the home-based environment conducive to providing 
an intervention that successfully improves targeted outcomes for breast cancer 
survivors. Also, the IT group revealed significantly greater improvements in a well 
known CVD and breast cancer risk factor (VO2max) compared to the MCT group.     
Therefore, clinicians may consider using IT when designing exercise programs for 
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breast cancer survivors. This dissertation has helped add to the field of knowledge 
related to breast cancer survivorship care. However, additional research will build upon 
our current work and may aid in improving the overall quality of life in breast cancer 
survivors; and possibly other populations of cancer survivors.       
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